To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene TMEM14CandTMEM14BandSYCP2LTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
957 supporting clones for gene TMEM14CandTMEM14BandSYCP2L back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB077181 testis .a 1 to 558 2 to 559   tiling clone, capped   558/558
(100 %)
4 diff
(99.3 %id)
TI_2194698548   .a 366 to 1009 430 to 1072   tiling clone, Submitted on the opposite strand 643/1279
(50 %)
27 diff
(97.9 %id)
DA620756   .a 868 to 1468 2 to 602   tiling clone, capped   601/601
(100 %)
0 diff
(100 %id)
BX281631 cervix .a 944 to 1428 1 to 485       485/485
(100 %)
0 diff
(100 %id)
BC012225 Placenta, choriocarcinoma .a 952 to 2916 9 to 1975 P366S tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 1967/1975
(99 %)
8 diff
(99.6 %id)
BE541431 cervix .a 966 to 1633 1 to 668   available from MGC,   668/800
(83 %)
23 diff
(97.2 %id)
AW674916 cervix .a 1545 to 2001 10 to 466       457/466
(98 %)
7 diff
(98.5 %id)
DB340631 testis .a 2319 to 2855 537 to 1       537/537
(100 %)
0 diff
(100 %id)
BM750187 stomach .a 2348 to 2884 1 to 537       537/537
(100 %)
0 diff
(100 %id)
BF590345 pooled .a 2403 to 2960 567 to 9       559/567
(98 %)
0 diff
(100 %id)
AW183165 pooled .a 2406 to 2861 456 to 1       456/456
(100 %)
0 diff
(100 %id)
AW663048 pooled .a 2427 to 2857 453 to 22   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 432/434
(99 %)
2 diff
(99.6 %id)
AA782841 parathyroid gland, parathyroid tumor .a 2492 to 2861 374 to 5       370/374
(98 %)
0 diff
(100 %id)
AA854950 parathyroid gland, parathyroid tumor .a 2499 to 2960 467 to 6       462/467
(98 %)
0 diff
(100 %id)
AI027433 parathyroid gland, parathyroid tumor .a 2553 to 2967 428 to 13   tiling clone, AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 416/416
(100 %)
1 diff
(99.8 %id)
BG198970   .a 2655 to 2842 201 to 15     Submitted on the opposite strand 187/202
(92 %)
0 diff
(100 %id)
AK294018 cerebellum .b 1 to 1888 2 to 1589   tiling clone, Suspected internal deletion 1589/1589
(100 %)
1 diff
(100.0 %id)
DA124086 cerebellum .b 1 to 504 2 to 505   capped   504/504
(100 %)
1 diff
(99.9 %id)
FN055423 breast carcinoma .b 1 to 95 97 to 3     Submitted on the opposite strand 95/97
(97 %)
0 diff
(100 %id)
FN109432 breast carcinoma .b 7 to 95 94 to 4     Submitted on the opposite strand 91/95
(95 %)
0 diff
(100 %id)
FN123243 breast carcinoma .b 7 to 86 80 to 1     Submitted on the opposite strand 80/81
(98 %)
1 diff
(98.8 %id)
DW453904 Liver .b 33 to 201 16 to 184       169/184
(91 %)
6 diff
(96.8 %id)
FN056918 breast carcinoma .b 48 to 154 105 to 1     Submitted on the opposite strand 105/105
(100 %)
2 diff
(98.1 %id)
AK310191 breast, tumor tissue .c 1 to 1033 1 to 1033 N116S H124R tiling clone,   1033/1033
(100 %)
4 diff
(99.7 %id)
DB004673 breast, tumor tissue .c 2 to 440 2 to 441   capped   440/440
(100 %)
1 diff
(99.8 %id)
CA405804 adipose .c 3 to 283 1 to 281       281/281
(100 %)
4 diff
(98.6 %id)
CN362726 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 4 to 313 1 to 310       310/310
(100 %)
1 diff
(99.7 %id)
FN143714 breast carcinoma .c 6 to 78 1 to 74       74/85
(87 %)
3 diff
(96.5 %id)
ES308258 beard hair, skin .c 21 to 224 1 to 204       204/204
(100 %)
0 diff
(100 %id)
AW407596 lymph .c 31 to 380 1 to 350       350/351
(99 %)
9 diff
(97.5 %id)
ES314572 occipital scalp hair, skin .c 34 to 230 1 to 196       196/196
(100 %)
4 diff
(98.0 %id)
AA093843   .c 37 to 326 1 to 283       283/297
(95 %)
11 diff
(96.3 %id)
CA947138 Pancreas, Purified pancreatic islet .c 37 to 319 1 to 283       283/283
(100 %)
0 diff
(100 %id)
BG560804   .c 135 to 326 198 to 3     Submitted on the opposite strand 196/219
(89 %)
13 diff
(94.1 %id)
EC480733 Prostate .c 173 to 265 90 to 1       90/90
(100 %)
2 diff
(97.8 %id)
CU442883 epidermis .c 174 to 327 1 to 154       154/168
(91 %)
11 diff
(93.5 %id)
CU443550 epidermis .c 174 to 327 1 to 154       154/168
(91 %)
11 diff
(93.5 %id)
CU443656 epidermis .c 174 to 327 1 to 154       154/168
(91 %)
11 diff
(93.5 %id)
CU445124 epidermis .c 174 to 327 1 to 154       154/168
(91 %)
11 diff
(93.5 %id)
CU445297 epidermis .c 174 to 327 1 to 154       154/168
(91 %)
11 diff
(93.5 %id)
CU445551 epidermis .c 174 to 327 1 to 154       154/168
(91 %)
11 diff
(93.5 %id)
CU445702 epidermis .c 174 to 327 1 to 154       154/168
(91 %)
11 diff
(93.5 %id)
CU446001 epidermis .c 174 to 327 1 to 154       154/168
(91 %)
11 diff
(93.5 %id)
CU447436 epidermis .c 174 to 327 1 to 154       154/168
(91 %)
11 diff
(93.5 %id)
CU448523 epidermis .c 174 to 327 1 to 154       154/168
(91 %)
11 diff
(93.5 %id)
CU449044 epidermis .c 174 to 327 1 to 154       154/168
(91 %)
10 diff
(94.1 %id)
CU449110 epidermis .c 174 to 327 1 to 154       154/168
(91 %)
11 diff
(93.5 %id)
CU449618 epidermis .c 174 to 327 1 to 154       154/168
(91 %)
11 diff
(93.5 %id)
CU449800 epidermis .c 174 to 327 1 to 154       154/168
(91 %)
11 diff
(93.5 %id)
CU450271 epidermis .c 174 to 327 1 to 154       154/168
(91 %)
11 diff
(93.5 %id)
CU450337 epidermis .c 174 to 327 1 to 154       154/168
(91 %)
11 diff
(93.5 %id)
CU451522 epidermis .c 174 to 327 1 to 154       154/168
(91 %)
11 diff
(93.5 %id)
CU451659 epidermis .c 174 to 327 1 to 154       154/168
(91 %)
11 diff
(93.5 %id)
CU452099 epidermis .c 174 to 327 1 to 154       154/168
(91 %)
11 diff
(93.5 %id)
CU452493 epidermis .c 174 to 327 1 to 154       154/168
(91 %)
11 diff
(93.5 %id)
CU452632 epidermis .c 174 to 327 1 to 154       154/168
(91 %)
11 diff
(93.5 %id)
CU453440 epidermis .c 174 to 327 1 to 154       154/168
(91 %)
11 diff
(93.5 %id)
CU454420 epidermis .c 174 to 327 1 to 154       154/168
(91 %)
11 diff
(93.5 %id)
CU455137 epidermis .c 174 to 327 1 to 154       154/168
(91 %)
13 diff
(92.3 %id)
CU455934 epidermis .c 174 to 327 1 to 154       154/168
(91 %)
11 diff
(93.5 %id)
CU456732 epidermis .c 174 to 327 1 to 154       154/168
(91 %)
11 diff
(93.5 %id)
CU457027 epidermis .c 174 to 327 1 to 154       154/168
(91 %)
11 diff
(93.5 %id)
CU442811 epidermis .c 176 to 336 166 to 5     Submitted on the opposite strand 162/168
(96 %)
5 diff
(97.1 %id)
CU444245 epidermis .c 176 to 336 166 to 5     Submitted on the opposite strand 162/168
(96 %)
5 diff
(97.1 %id)
CU444860 epidermis .c 176 to 336 166 to 5     Submitted on the opposite strand 162/168
(96 %)
5 diff
(97.1 %id)
CU445413 epidermis .c 176 to 336 166 to 5     Submitted on the opposite strand 162/168
(96 %)
5 diff
(97.1 %id)
CU445586 epidermis .c 176 to 336 166 to 5     Submitted on the opposite strand 162/168
(96 %)
5 diff
(97.1 %id)
CU446005 epidermis .c 176 to 336 166 to 5     Submitted on the opposite strand 162/168
(96 %)
5 diff
(97.1 %id)
CU446109 epidermis .c 176 to 323 166 to 9     Submitted on the opposite strand 168/168
(100 %)
61 diff
(63.7 %id)
CU446226 epidermis .c 176 to 336 166 to 5     Submitted on the opposite strand 162/168
(96 %)
4 diff
(97.7 %id)
CU446725 epidermis .c 176 to 323 163 to 6     Submitted on the opposite strand 168/165
(101 %)
61 diff
(63.1 %id)
CU446750 epidermis .c 176 to 336 166 to 5     Submitted on the opposite strand 162/168
(96 %)
5 diff
(97.1 %id)
CU447150 epidermis .c 176 to 336 166 to 5     Submitted on the opposite strand 162/168
(96 %)
5 diff
(97.1 %id)
CU447595 epidermis .c 176 to 336 166 to 5     Submitted on the opposite strand 162/168
(96 %)
5 diff
(97.1 %id)
CU447711 epidermis .c 176 to 336 166 to 5     Submitted on the opposite strand 162/168
(96 %)
5 diff
(97.1 %id)
CU448225 epidermis .c 176 to 336 166 to 5     Submitted on the opposite strand 162/168
(96 %)
5 diff
(97.1 %id)
CU448533 epidermis .c 176 to 336 166 to 5     Submitted on the opposite strand 162/168
(96 %)
5 diff
(97.1 %id)
CU448815 epidermis .c 176 to 336 166 to 5     Submitted on the opposite strand 162/168
(96 %)
5 diff
(97.1 %id)
CU449086 epidermis .c 176 to 336 166 to 5     Submitted on the opposite strand 162/168
(96 %)
5 diff
(97.1 %id)
CU449191 epidermis .c 176 to 336 166 to 5     Submitted on the opposite strand 162/168
(96 %)
5 diff
(97.1 %id)
CU450028 epidermis .c 176 to 336 166 to 5     Submitted on the opposite strand 162/168
(96 %)
5 diff
(97.1 %id)
CU451112 epidermis .c 176 to 336 166 to 5     Submitted on the opposite strand 162/168
(96 %)
5 diff
(97.1 %id)
CU451267 epidermis .c 176 to 336 166 to 5     Submitted on the opposite strand 162/168
(96 %)
5 diff
(97.1 %id)
CU451517 epidermis .c 176 to 336 166 to 5     Submitted on the opposite strand 162/168
(96 %)
5 diff
(97.1 %id)
CU451771 epidermis .c 176 to 323 166 to 9     Submitted on the opposite strand 168/168
(100 %)
61 diff
(63.7 %id)
CU451800 epidermis .c 176 to 323 166 to 9     Submitted on the opposite strand 168/168
(100 %)
61 diff
(63.7 %id)
CU452058 epidermis .c 176 to 336 166 to 5     Submitted on the opposite strand 162/168
(96 %)
5 diff
(97.1 %id)
CU452106 epidermis .c 176 to 323 166 to 9     Submitted on the opposite strand 168/168
(100 %)
61 diff
(63.7 %id)
CU452604 epidermis .c 176 to 336 166 to 5     Submitted on the opposite strand 162/168
(96 %)
5 diff
(97.1 %id)
CU452917 epidermis .c 176 to 336 166 to 5     Submitted on the opposite strand 162/168
(96 %)
5 diff
(97.1 %id)
CU452939 epidermis .c 176 to 336 166 to 5     Submitted on the opposite strand 162/168
(96 %)
5 diff
(97.1 %id)
CU453653 epidermis .c 176 to 326 165 to 15     Submitted on the opposite strand 151/167
(90 %)
5 diff
(97.1 %id)
CU454149 epidermis .c 176 to 336 166 to 5     Submitted on the opposite strand 162/168
(96 %)
5 diff
(97.1 %id)
CU454967 epidermis .c 176 to 336 166 to 5     Submitted on the opposite strand 162/168
(96 %)
5 diff
(97.1 %id)
CU455008 epidermis .c 176 to 323 166 to 10     Submitted on the opposite strand 166/168
(98 %)
61 diff
(63.7 %id)
CU455420 epidermis .c 176 to 323 166 to 9     Submitted on the opposite strand 168/168
(100 %)
61 diff
(63.7 %id)
CU455504 epidermis .c 176 to 336 166 to 5     Submitted on the opposite strand 162/168
(96 %)
5 diff
(97.1 %id)
CU455910 epidermis .c 176 to 336 166 to 5     Submitted on the opposite strand 162/168
(96 %)
5 diff
(97.1 %id)
CU455984 epidermis .c 176 to 336 166 to 5     Submitted on the opposite strand 162/168
(96 %)
5 diff
(97.1 %id)
CU456310 epidermis .c 176 to 336 166 to 5     Submitted on the opposite strand 162/168
(96 %)
5 diff
(97.1 %id)
CU456336 epidermis .c 176 to 336 163 to 2     Submitted on the opposite strand 162/165
(98 %)
5 diff
(97.0 %id)
CU456502 epidermis .c 176 to 323 166 to 9     Submitted on the opposite strand 168/168
(100 %)
61 diff
(63.7 %id)
CU456644 epidermis .c 176 to 336 166 to 5     Submitted on the opposite strand 162/168
(96 %)
5 diff
(97.1 %id)
CU457050 epidermis .c 176 to 336 166 to 5     Submitted on the opposite strand 162/168
(96 %)
5 diff
(97.1 %id)
CU457089 epidermis .c 176 to 336 166 to 5     Submitted on the opposite strand 162/168
(96 %)
5 diff
(97.1 %id)
CU457342 epidermis .c 177 to 327 4 to 154       151/168
(89 %)
10 diff
(94.1 %id)
CU453319 epidermis .c 187 to 327 1 to 141       141/155
(90 %)
12 diff
(92.3 %id)
BF771772 epid_tumor .d 1 to 193 1 to 197   tiling clone,   197/207
(95 %)
16 diff
(92.3 %id)
BX095003 liver and spleen .d 65 to 792 1 to 728   tiling clone,   728/728
(100 %)
0 diff
(100 %id)
CD724012 eye, lacrimal gland .d 103 to 731 1 to 629       629/629
(100 %)
0 diff
(100 %id)
H75288 liver and spleen .d 107 to 428 1 to 324       324/399
(81 %)
3 diff
(99.3 %id)
TI_1968235771   .d 692 to 1520 1075 to 253 P49S tiling clone,   823/1241
(66 %)
8 diff
(99.4 %id)
BP307737 brain .e 1 to 590 5 to 594 exact tiling clone,   594/594
(100 %)
0 diff
(100 %id)
BM762178 myeloma .e 1 to 407 1 to 406       406/406
(100 %)
1 diff
(99.8 %id)
DB021036 testis .e 2 to 464 2 to 463   capped   462/462
(100 %)
3 diff
(99.4 %id)
AA326688 brain, cerebellum .e 16 to 367 1 to 352       352/352
(100 %)
0 diff
(100 %id)
BG432075 Kidney .e 26 to 739 1 to 715 P143T H144N L149R Y150I tiling clone,   715/716
(99 %)
10 diff
(98.7 %id)
BG760373 melanotic melanoma, high MDR (cell line), skin .e 36 to 364 1 to 334       334/928
(35 %)
11 diff
(98.9 %id)
CN260945 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 41 to 392 1 to 352       352/352
(100 %)
6 diff
(98.3 %id)
R57473   .e 88 to 364 1 to 276       276/278
(99 %)
3 diff
(99.0 %id)
AA372693 colon .e 121 to 360 1 to 240       240/240
(100 %)
0 diff
(100 %id)
CV028863 mixed .e 122 to 376 1 to 258       258/258
(100 %)
9 diff
(96.6 %id)
AK294152 alzheimer cortex .f 1 to 992 1 to 992 exact tiling clone,   992/992
(100 %)
0 diff
(100 %id)
DC312702 alzheimer cortex .f 1 to 547 1 to 547 exact     547/547
(100 %)
0 diff
(100 %id)
DC381025 placenta .f 1 to 559 1 to 559 exact     559/559
(100 %)
0 diff
(100 %id)
BP364895 lung .f 1 to 593 1 to 593 S112N     593/593
(100 %)
1 diff
(99.9 %id)
AK309591 Liver .g 1 to 1002 1 to 1002 exact tiling clone,   1002/1002
(100 %)
6 diff
(99.5 %id)
DC362719 Liver .g 1 to 494 1 to 494       494/494
(100 %)
2 diff
(99.6 %id)
N43927 multiple sclerosis lesions .h 1 to 387 1 to 387 R15V P17X A18R A19R A20C ... tiling clone,   387/387
(100 %)
5 diff
(98.8 %id)
BM764385 Ascites, stomach .h 13 to 497 10 to 494   tiling clone,   485/485
(100 %)
0 diff
(100 %id)
N42142 melanocyte .h 20 to 472 1 to 456       456/456
(100 %)
9 diff
(98.1 %id)
N34854 multiple sclerosis lesions .h 452 to 834 383 to 1   tiling clone,   383/383
(100 %)
1 diff
(99.8 %id)
BQ056988 lymph, lymphoma, cell line .i 1 to 908 26 to 946 exact tiling clone,   921/947
(97 %)
32 diff
(96.7 %id)
BQ055859 lymph, lymphoma, cell line .i 2 to 861 1 to 867 exact     867/1080
(80 %)
18 diff
(98.4 %id)
TI_149315087   .i 326 to 1099 841 to 79   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 763/953
(80 %)
15 diff
(98.5 %id)
BQ045109 lung, Primary Lung Cystic Fibrosis EpithelialCells .i 519 to 1099 596 to 16   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 581/581
(100 %)
1 diff
(99.9 %id)
AI343263 colon, colon tumor, RER+ .i 606 to 1119 533 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 515/516
(99 %)
3 diff
(99.5 %id)
TI_159722053   .i 654 to 1646 1070 to 86   tiling clone, AAA   985/1042
(94 %)
14 diff
(98.7 %id)
AV724683 hypothalamus .i 712 to 1272 1 to 554       554/555
(99 %)
4 diff
(99.3 %id)
AI161195 brain, glioblastoma (pooled) .i 733 to 1099 367 to 1       367/367
(100 %)
1 diff
(99.8 %id)
CA944423 Human Lung Epithelial cells, lung .i 960 to 1646 704 to 19   AAA   686/686
(100 %)
2 diff
(99.8 %id)
AW991938 breast_normal .i 1076 to 1428 1 to 353   tiling clone,   353/353
(100 %)
2 diff
(99.5 %id)
AW991939 breast_normal .i 1076 to 1417 345 to 4     Submitted on the opposite strand 342/346
(98 %)
0 diff
(100 %id)
AA602479 adrenal adenoma, adrenal gland .i 1453 to 1646 246 to 54   AAA   193/193
(100 %)
3 diff
(98.5 %id)
BI597759 brain, hypothalamus .j 1 to 621 8 to 627 G76V V77L M78W G79E M80* AAA   627/627
(100 %)
5 diff
(99.3 %id)
TI_45213690   .j 1 to 621 94 to 713 G76V V77L M78W G79E M80* AAA   623/713
(87 %)
7 diff
(99.1 %id)
TI_57218037   .j 1 to 748 22 to 768 exact     749/770
(97 %)
10 diff
(98.8 %id)
TI_57171159   .j 1 to 875 28 to 901 exact     876/927
(94 %)
36 diff
(96.2 %id)
DB497759 hypothalamus .j 1 to 494 2 to 495   tiling clone,   495/495
(100 %)
1 diff
(99.8 %id)
NM_030969.3   .j 1 to 964 1 to 964 exact RefSeq, AAA   964/964
(100 %)
0 diff
(100 %id)
BF972946 leiomyosarcoma cell line, uterus .j 5 to 621 1 to 615 F14L G15A F16L G17A Y18T ... AAA   615/615
(100 %)
3 diff
(99.6 %id)
BI551100 brain, hippocampus .j 5 to 724 1 to 715 exact     715/715
(100 %)
11 diff
(98.5 %id)
BI552632 brain, hippocampus .j 5 to 659 1 to 663 F16L G17W Y18P A20Q L21H ...     663/745
(88 %)
36 diff
(95.2 %id)
BF972692 leiomyosarcoma cell line, uterus .j 6 to 621 1 to 620 S24L V31C K32N T33N G34R ... AAA   620/620
(100 %)
30 diff
(95.2 %id)
BI830613 brain, medulla .j 6 to 875 1 to 869 exact     869/895
(97 %)
31 diff
(96.6 %id)
BP316712 pericardium .j 13 to 595 1 to 583 exact     583/583
(100 %)
0 diff
(100 %id)
BI753272 brain .j 15 to 748 1 to 733 exact     733/735
(99 %)
2 diff
(99.8 %id)
BF726887 eye, lens .j 17 to 538 1 to 522 exact     522/522
(100 %)
0 diff
(100 %id)
CR623943 Neuroblastoma Cot 10-normalized .j 17 to 970 1 to 954 exact     954/954
(100 %)
0 diff
(100 %id)
AL519643 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .j 17 to 970 1 to 950 exact fully sequenced,   950/950
(100 %)
15 diff
(98.5 %id)
BE961088 melanotic melanoma, high MDR, skin .j 17 to 539 1 to 522 V105L G106E V107F R108V M109C ...     522/522
(100 %)
3 diff
(99.5 %id)
CB270803 adipose .j 18 to 587 1 to 575 G96X S98X A103R K104Q V105K ...     575/582
(98 %)
8 diff
(98.7 %id)
BG536454 lung .j 24 to 660 1 to 633 F14L G15A F16L G17A Y18T ...     633/808
(78 %)
23 diff
(97.2 %id)
CD700563 normal nasopharynx .j 26 to 550 32 to 556 exact     525/556
(94 %)
6 diff
(99.0 %id)
BU502285 mixed (pool of 40 RNAs) .j 26 to 628 1 to 603 exact     603/603
(100 %)
0 diff
(100 %id)
BU541808 carcinoma, cell line, Prostate .j 26 to 676 12 to 671 exact     660/1002
(65 %)
28 diff
(97.3 %id)
BQ935722 carcinoma, cell line, Prostate .j 27 to 853 1 to 834 exact AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 834/834
(100 %)
10 diff
(98.9 %id)
AV734719 pheochromocytoma .j 28 to 620 1 to 592 exact     592/596
(99 %)
3 diff
(99.5 %id)
BG707092 brain, hypothalamus .j 28 to 842 1 to 826 exact     826/844
(97 %)
32 diff
(96.3 %id)
BI603269 brain, hypothalamus .j 28 to 926 1 to 894 V28F     894/982
(91 %)
66 diff
(93.3 %id)
TI_45210703   .j 29 to 926 125 to 1017 V28F     893/1105
(80 %)
69 diff
(93.8 %id)
BP234356 coronary artery .j 33 to 615 1 to 583 A103R K104Q     583/583
(100 %)
2 diff
(99.7 %id)
BM852049 stomach .j 33 to 470 1 to 438       438/438
(100 %)
1 diff
(99.8 %id)
BU581665 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .j 34 to 642 4 to 612 exact     609/612
(99 %)
6 diff
(99.1 %id)
AA312807   .j 35 to 584 1 to 550 S38F     550/550
(100 %)
2 diff
(99.7 %id)
CD708809 normal nasopharynx .j 35 to 563 33 to 561 K87T I94L     529/561
(94 %)
9 diff
(98.4 %id)
DW410600 Liver .j 35 to 359 9 to 333       325/333
(97 %)
5 diff
(98.5 %id)
DW433533 Liver .j 35 to 293 9 to 262       254/262
(96 %)
10 diff
(96.2 %id)
BF666828 brain, primitive neuroectoderm .j 35 to 654 1 to 623 L8I V9S P10A H12V W13D ...     623/924
(67 %)
53 diff
(94.3 %id)
BF701098 brain, primitive neuroectoderm .j 35 to 704 1 to 664 H12X G76V V77Y M78G G79N ...     664/668
(99 %)
34 diff
(95.0 %id)
BC013913 Bladder, carcinoma .j 36 to 943 1 to 908 exact available from MGC, AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 908/908
(100 %)
3 diff
(99.7 %id)
BE739243 hypernephroma, Kidney .j 36 to 632 1 to 594 W13G F14W G15L F16W G17L ...     594/645
(92 %)
16 diff
(97.6 %id)
CB962922 Blood vessels - aorta, basilar and artery .j 37 to 682 1 to 651 F74L V75L G76V V77L M78W ...     651/779
(83 %)
14 diff
(98.3 %id)
BU158904 large cell carcinoma, lung .j 38 to 900 1 to 868 exact     868/920
(94 %)
20 diff
(97.9 %id)
BG401525 Kidney .j 39 to 684 1 to 638 V105L G106E V107F R108V M109C ...     638/762
(83 %)
17 diff
(97.8 %id)
BU534094 mixed (pool of 40 RNAs) .j 39 to 620 1 to 582 exact     582/615
(94 %)
5 diff
(99.2 %id)
BG532272 embryonal carcinoma, testis .j 40 to 635 1 to 592 V105L G106E V107F R108V M109C ...     592/607
(97 %)
4 diff
(99.4 %id)
CN260943 embryonic stem cells, DMSO-treated H9 cellline .j 41 to 298 1 to 258       258/258
(100 %)
0 diff
(100 %id)
BG025562 lymph, lymphoma, cell line .j 41 to 748 1 to 710 exact     710/959
(74 %)
12 diff
(98.8 %id)
BG170723 hypernephroma, cell line, Kidney .j 41 to 762 1 to 718 F74L V75L G76V V77L M78W ...     718/774
(92 %)
13 diff
(98.4 %id)
BI334054 cervical carcinoma cell line, cervix .j 41 to 735 1 to 696 exact     696/696
(100 %)
12 diff
(98.3 %id)
BG536368 lung .j 42 to 795 1 to 749 W13X     749/749
(100 %)
12 diff
(98.4 %id)
BG611094 adenocarcinoma, Prostate .j 42 to 859 1 to 811 exact     811/814
(99 %)
17 diff
(98.0 %id)
BG573465 placenta .j 43 to 784 1 to 748 exact     748/828
(90 %)
11 diff
(98.7 %id)
BM454862 leiomyosarcoma, uterus .j 43 to 828 1 to 799 exact     799/978
(81 %)
25 diff
(97.5 %id)
BP199286 brain .j 44 to 621 1 to 578 A103T AAA   578/578
(100 %)
1 diff
(99.9 %id)
AK291883 skeletal muscle .j 44 to 971 1 to 928 S82F     928/928
(100 %)
1 diff
(99.9 %id)
BC007080 Brain, glioblastoma .j 44 to 964 1 to 922 P37S Y83C tiling clone, available from MGC, AAA   922/922
(100 %)
3 diff
(99.7 %id)
BP204260 coronary artery .j 44 to 624 1 to 581 exact     581/581
(100 %)
0 diff
(100 %id)
BP234779 coronary artery .j 44 to 630 1 to 587 V105X     587/587
(100 %)
3 diff
(99.5 %id)
BP249582 Kidney .j 44 to 626 1 to 583 exact     583/583
(100 %)
5 diff
(99.2 %id)
BF666742 brain, primitive neuroectoderm .j 44 to 693 1 to 630 W13G F14W G15L F16G G17Y ...     630/837
(75 %)
21 diff
(97.5 %id)
BP337129 coronary artery .j 44 to 629 1 to 587 K104*     587/587
(100 %)
3 diff
(99.5 %id)
BE876001 large cell carcinoma, undifferentiated, lung .j 45 to 741 1 to 694 W13G F14L G15A F16L G17A ...     694/743
(93 %)
18 diff
(97.6 %id)
DA896226 skeletal muscle .j 45 to 611 2 to 568 S82F capped   567/567
(100 %)
1 diff
(99.9 %id)
CN260947 embryonic stem cells, cell lines H1, H7, andH9 .j 46 to 661 1 to 616 exact     616/616
(100 %)
4 diff
(99.4 %id)
CA777789 Pancreas, Purified pancreatic islet .j 47 to 397 1 to 351   fully sequenced,   351/351
(100 %)
8 diff
(97.8 %id)
BG329144 eye, retinoblastoma .j 48 to 750 1 to 710 W13G F14L G15A F16L G17A ...     710/889
(79 %)
29 diff
(96.8 %id)
AA299454 uterus .j 49 to 333 1 to 288       288/292
(98 %)
7 diff
(97.7 %id)
BF697509 brain, primitive neuroectoderm .j 49 to 666 1 to 626 W13G F14W G15L F16W G17L ...     626/743
(84 %)
23 diff
(97.0 %id)
BG535342 lung .j 49 to 718 1 to 673 Y18C L110S     673/812
(82 %)
22 diff
(97.3 %id)
BI756920 brain .j 49 to 798 1 to 753 W13G F14W G15L F16W G17L ...     753/844
(89 %)
26 diff
(97.0 %id)
TI_57220172   .j 49 to 798 34 to 786 W13G F14W G15L F16W G17L ...     753/877
(85 %)
31 diff
(96.5 %id)
DN991175 brain, whole brain .j 49 to 672 1 to 624 exact     624/624
(100 %)
2 diff
(99.7 %id)
BU664047 blood .j 50 to 621 9 to 580 exact AAA   572/580
(98 %)
6 diff
(99.0 %id)
DB505085 hypothalamus .j 50 to 504 1 to 455       455/455
(100 %)
1 diff
(99.8 %id)
BP260906 small intestine .j 50 to 621 1 to 572 exact AAA   572/572
(100 %)
0 diff
(100 %id)
BP261552 small intestine .j 50 to 626 1 to 576 A20G     576/576
(100 %)
5 diff
(99.2 %id)
BU157024 epithelioid carcinoma, Pancreas .j 50 to 723 1 to 676 exact     676/787
(85 %)
5 diff
(99.4 %id)
CN260946 embryonic stem cells, DMSO-treated H9 cellline .j 53 to 562 1 to 510 exact     510/519
(98 %)
4 diff
(99.3 %id)
BF028243 bladder, carcinoma, cell line .j 55 to 737 1 to 674 F74L V75W G76V V77L M78W ...     674/842
(80 %)
18 diff
(97.9 %id)
BC001033 Placenta, choriocarcinoma .j 56 to 964 1 to 910 G42W available from MGC, AAA   910/910
(100 %)
2 diff
(99.8 %id)
CD695385 normal nasopharynx .j 56 to 541 32 to 517 F16L     486/517
(94 %)
7 diff
(98.7 %id)
BE280989 choriocarcinoma, placenta .j 56 to 616 33 to 597 G42W     565/600
(94 %)
15 diff
(97.5 %id)
BG331581 large cell carcinoma, lung .j 56 to 748 1 to 695 exact     695/973
(71 %)
12 diff
(98.8 %id)
BG421788 Kidney, renal cell adenocarcinoma .j 56 to 759 1 to 709 exact     709/778
(91 %)
13 diff
(98.4 %id)
BG708612 brain, hypothalamus .j 56 to 789 1 to 730 W13G F14L G15A F16L G17A ...     730/730
(100 %)
16 diff
(97.9 %id)
BI226648 Burkitt lymphoma, lymph .j 56 to 658 1 to 603 W13G F14L G15A F16L G17A ...     603/603
(100 %)
4 diff
(99.4 %id)
BQ648812 hepatocellular carcinoma, cell line, Liver .j 56 to 916 17 to 890 exact     874/891
(98 %)
42 diff
(95.3 %id)
BF691779 melanotic melanoma, high MDR, skin .j 57 to 706 1 to 659 W64G G65V F66S L67*     659/777
(84 %)
20 diff
(97.5 %id)
BI832780 pooled pancreas and spleen .j 57 to 792 1 to 734 F74X G76V V77L M78W G79E ...     734/734
(100 %)
10 diff
(98.7 %id)
BI836283 pooled pancreas and spleen .j 57 to 793 1 to 725 L11C H12M W13V F14G G15L ...     725/725
(100 %)
14 diff
(98.1 %id)
CA487256   .j 57 to 938 1 to 895 exact     895/896
(99 %)
36 diff
(96.0 %id)
CD356521 Blood vessels - aorta, basilar and artery .j 57 to 805 1 to 762 exact     762/785
(97 %)
23 diff
(97.1 %id)
TI_57162420   .j 57 to 792 32 to 765 F74X G76V V77L M78W G79E ...     734/765
(95 %)
16 diff
(98.0 %id)
TI_57163541   .j 57 to 793 28 to 752 L11C H12M W13V F14G G15L ...     725/752
(96 %)
19 diff
(97.5 %id)
CB130241 Liver .j 57 to 622 1 to 566 exact     566/566
(100 %)
0 diff
(100 %id)
CN260936 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .j 58 to 621 1 to 564 exact AAA   564/564
(100 %)
6 diff
(99.0 %id)
AV721356 hypothalamus .j 58 to 617 1 to 560 exact     560/563
(99 %)
1 diff
(99.9 %id)
BF217992 brain, glioblastoma .j 58 to 751 1 to 689 L11C H12A W13L F14V G15W ...     689/691
(99 %)
27 diff
(96.1 %id)
BQ064529 lymph, lymphoma, cell line .j 58 to 931 1 to 889 exact     889/940
(94 %)
22 diff
(97.7 %id)
N55991   .j 58 to 327 1 to 265       265/265
(100 %)
6 diff
(97.8 %id)
BQ638022 eye, retina .j 59 to 658 1 to 600 S47R     600/600
(100 %)
1 diff
(99.9 %id)
BG752760 eye, normal pigmented retinal epithelium .j 60 to 795 1 to 729 L11C H12M W13V F14G G15L ...     732/730
(100 %)
19 diff
(97.4 %id)
BI258406 cervical carcinoma cell line, cervix .j 60 to 735 1 to 675 L51W G52V A53L Y54T Q55S ...     675/675
(100 %)
2 diff
(99.8 %id)
BQ918834 brain, neuroblastoma, cell line .j 60 to 959 1 to 919 exact AAA   919/981
(93 %)
51 diff
(94.9 %id)
BG423855 Kidney, renal cell adenocarcinoma .j 62 to 739 1 to 687 exact     687/855
(80 %)
31 diff
(96.4 %id)
BG823904 adenocarcinoma cell line, colon .j 62 to 748 1 to 687 exact     687/806
(85 %)
7 diff
(99.2 %id)
CN260941 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .j 63 to 718 12 to 667 exact     656/667
(98 %)
6 diff
(99.2 %id)
CN260942 embryonic stem cells, cell lines H1, H7, andH9 .j 63 to 286 1 to 224       224/224
(100 %)
2 diff
(99.2 %id)
BE904995 epithelioid carcinoma, Pancreas .j 63 to 632 579 to 12 L39W A40L A41Q L43C L44S ...   Submitted on the opposite strand 568/879
(64 %)
2 diff
(99.8 %id)
BG398187 B-cells, primary B-cells from tonsils (cell line) .j 63 to 752 1 to 687 exact     687/894
(76 %)
20 diff
(97.8 %id)
BG473689 eye, retinoblastoma .j 63 to 639 1 to 578 exact     578/578
(100 %)
2 diff
(99.7 %id)
CN260939 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .j 64 to 630 1 to 567 exact     567/567
(100 %)
0 diff
(100 %id)
BI334426 cervical carcinoma cell line, cervix .j 64 to 746 13 to 691 W13G F14W G15L F16W G17L ...     679/691
(98 %)
11 diff
(98.5 %id)
CR622176 Neuroblastoma Cot 25-normalized .j 65 to 972 1 to 908 exact tiling clone,   908/908
(100 %)
0 diff
(100 %id)
BX395104 Neuroblastoma Cot 25-normalized .j 65 to 972 1 to 908 exact fully sequenced,   908/908
(100 %)
2 diff
(99.8 %id)
BC071660 Liver, adenocarcinoma .j 66 to 964 13 to 911 exact available from MGC, AAA   899/899
(100 %)
0 diff
(100 %id)
BG252431 adenocarcinoma, cell line, Liver .j 66 to 791 11 to 741 exact     731/992
(73 %)
38 diff
(96.2 %id)
BG548272 lung .j 66 to 772 1 to 710 exact     710/763
(93 %)
25 diff
(96.8 %id)
TI_57228461   .j 66 to 621 49 to 604 exact AAA   556/556
(100 %)
1 diff
(99.9 %id)
AA305409 colon .j 67 to 512 105 to 549 L93*     445/451
(98 %)
9 diff
(98.1 %id)
BI870726 adenocarcinoma, cell line, Liver .j 67 to 621 1 to 555 exact AAA   555/555
(100 %)
1 diff
(99.9 %id)
BM477852 leiomyosarcoma, uterus .j 67 to 929 6 to 875 exact     870/1072
(81 %)
34 diff
(96.9 %id)
CX751292 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .j 67 to 754 1 to 688 exact   Submitted on the opposite strand 688/690
(99 %)
5 diff
(99.3 %id)
BM888344 eye .j 68 to 571 1 to 504 exact     504/508
(99 %)
1 diff
(99.9 %id)
BE253888 eye, retinoblastoma .j 68 to 788 1 to 714 W13G F14W G15L F16W G17L ...     714/916
(77 %)
18 diff
(98.1 %id)
BE866570 bladder, carcinoma, cell line .j 69 to 662 1 to 587 L11C H12I W13G F14W G15L ...     587/681
(86 %)
24 diff
(96.5 %id)
BE440008 Trabecular meshwork .j 70 to 819 1 to 749 F16X     749/749
(100 %)
7 diff
(99.1 %id)
CN260937 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .j 70 to 812 5 to 747 exact     743/747
(99 %)
5 diff
(99.4 %id)
BQ638795 eye, retina .j 70 to 570 15 to 515 exact     501/515
(97 %)
6 diff
(98.9 %id)
BF244338 brain, glioblastoma .j 71 to 603 1 to 536 G15W F16L G17W Y18L T19H ...     536/814
(65 %)
12 diff
(98.6 %id)
AA332809 Embryo, 8 weeks .j 72 to 339 1 to 269       269/269
(100 %)
1 diff
(99.7 %id)
BQ440070 melanotic melanoma, skin .j 72 to 929 1 to 861 V9A V28G G92C     861/865
(99 %)
26 diff
(97.0 %id)
ES308011 beard hair, skin .j 75 to 283 1 to 209       209/209
(100 %)
0 diff
(100 %id)
BM465869 eye, retinoblastoma .j 76 to 703 1 to 628 A49T A68T S98R K104E R108Q ... AAA   628/985
(63 %)
37 diff
(96.3 %id)
TI_57162709   .j 76 to 831 29 to 787 H12R V23F S24L G25V I27S ...     759/790
(96 %)
24 diff
(97.0 %id)
TI_57167041   .j 76 to 752 36 to 719 W13L F14V G15W F16L G17W ...     684/726
(94 %)
20 diff
(97.3 %id)
BE380086 bladder, carcinoma, cell line .j 77 to 738 1 to 656 S24L G25V I27S V28L G29A ...     656/854
(76 %)
19 diff
(97.8 %id)
BI836411 pooled pancreas and spleen .j 77 to 831 1 to 758 H12R V23F S24L G25V I27S ...     758/761
(99 %)
18 diff
(97.7 %id)
BI835166 pooled pancreas and spleen .j 77 to 752 1 to 683 W13L F14V G15W F16L G17W ...     683/690
(98 %)
14 diff
(98.0 %id)
CK002535 brain/CNS, Bulk tissue from Human Spinal cord .j 77 to 716 1 to 635 exact     635/638
(99 %)
10 diff
(98.5 %id)
BM561887 blood, natural killer cells, cell line .j 78 to 968 12 to 905 exact AAA   894/905
(98 %)
17 diff
(98.2 %id)
BG760292 melanotic melanoma, high MDR (cell line), skin .j 79 to 748 1 to 669 exact     669/671
(99 %)
3 diff
(99.6 %id)
BE784090 eye, retinoblastoma .j 84 to 748 1 to 664 exact     664/664
(100 %)
2 diff
(99.7 %id)
CN260940 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .j 86 to 557 1 to 472 A68P     472/472
(100 %)
2 diff
(99.6 %id)
BI457157 epithelioid carcinoma cell line, Pancreas .j 86 to 738 1 to 658 G76V V77L M78W G79E M80*     658/692
(95 %)
11 diff
(98.5 %id)
TI_45133397   .j 87 to 738 59 to 715 G76V V77L M78W G79E M80*     657/691
(95 %)
10 diff
(98.6 %id)
BF036389 adenocarcinoma, ovary .j 88 to 826 1 to 742 F74L V75L G76V V77L M78W ...     742/928
(79 %)
27 diff
(97.1 %id)
AV711565 adrenal cortico adenoma for Cushing'ssyndrome .j 92 to 860 1 to 760 S35G     760/793
(95 %)
46 diff
(94.2 %id)
CR746345 epithelioid carcinoma, Pancreas .j 93 to 586 6 to 499 exact     494/499
(98 %)
6 diff
(98.8 %id)
BM781841 myeloma .j 94 to 688 1 to 595 exact     595/595
(100 %)
0 diff
(100 %id)
BP249364 Kidney .j 96 to 653 1 to 557 exact     557/588
(94 %)
2 diff
(99.7 %id)
BE883738 leiomyosarcoma, uterus .j 97 to 717 1 to 627 exact     627/895
(70 %)
13 diff
(98.6 %id)
BF248231 melanotic melanoma, high MDR, skin .j 99 to 760 1 to 666 W13G F14W G15L F16G G17T ...     666/793
(83 %)
47 diff
(94.1 %id)
BQ218345 epithelioid carcinoma, Pancreas .j 101 to 971 1 to 890 exact     890/913
(97 %)
38 diff
(95.9 %id)
AA329750   .j 102 to 363 1 to 265       265/272
(97 %)
4 diff
(98.6 %id)
BE874970 large cell carcinoma, undifferentiated, lung .j 107 to 616 1 to 505 W13G F14W G15L F16W G17L ...     505/505
(100 %)
5 diff
(99.1 %id)
BG165235 hypernephroma, cell line, Kidney .j 107 to 759 1 to 654 W13G F14L G15A F16L G17A ...     654/926
(70 %)
16 diff
(98.3 %id)
CA397649 eye, RPE/choroid .j 113 to 647 1 to 535 exact     535/535
(100 %)
4 diff
(99.3 %id)
EL946408 eyeball .j 113 to 668 51 to 601 exact     551/601
(91 %)
10 diff
(98.4 %id)
CN260944 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .j 120 to 492 1 to 373       373/373
(100 %)
0 diff
(100 %id)
TI_149296977   .j 142 to 971 901 to 78 P10L L11C H12I W13G F14W ... AAA   824/946
(87 %)
12 diff
(98.8 %id)
CD675350 eye, lens .j 160 to 774 1 to 614 E2*     614/614
(100 %)
8 diff
(98.7 %id)
CV027470 mixed .j 165 to 508 1 to 344       344/539
(63 %)
3 diff
(99.5 %id)
EL736986 mixed .j 165 to 508 1 to 344       344/505
(68 %)
1 diff
(99.9 %id)
TI_1948229688   .j 165 to 508 140 to 483       344/806
(42 %)
7 diff
(99.2 %id)
TI_1948230009   .j 165 to 508 141 to 484       344/882
(39 %)
7 diff
(99.3 %id)
TI_1948230161   .j 165 to 508 134 to 478       345/889
(38 %)
10 diff
(98.9 %id)
AA229940   .j 171 to 517 351 to 6       346/351
(98 %)
3 diff
(99.2 %id)
BE543360.
matches multiple genes
cervical carcinoma cell line, cervix .j 183 to 748 1 to 556   tiling clone, also hits gene korsmey 556/736
(75 %)
21 diff
(97.2 %id)
TI_149290687   .j 183 to 971 868 to 84   AAA   785/965
(81 %)
21 diff
(97.9 %id)
TI_159724105   .j 188 to 971 863 to 82   AAA   782/1011
(77 %)
11 diff
(99.0 %id)
TI_227712365   .j 188 to 968 840 to 62   AAA   779/976
(79 %)
5 diff
(99.5 %id)
TI_149311572   .j 192 to 971 875 to 98   AAA   778/939
(82 %)
9 diff
(99.1 %id)
TI_149309737   .j 205 to 971 853 to 88   AAA   766/959
(79 %)
5 diff
(99.5 %id)
AI631124 Kidney, renal cell tumor .j 207 to 622 416 to 1       416/416
(100 %)
0 diff
(100 %id)
TI_149290750   .j 211 to 971 844 to 88   AAA   757/980
(77 %)
10 diff
(99.0 %id)
BG941498 blood .j 221 to 621 431 to 31   AAA   401/401
(100 %)
1 diff
(99.8 %id)
BU556706 ovary, teratocarcinoma, cell line .j 232 to 971 1 to 741   AAA   741/741
(100 %)
3 diff
(99.6 %id)
CD367082 Alveolar Macrophage, lung .j 232 to 968 750 to 15   AAA   736/736
(100 %)
2 diff
(99.8 %id)
BM982121 lung, Primary Lung Cystic Fibrosis EpithelialCells .j 237 to 971 749 to 16   AAA   734/734
(100 %)
4 diff
(99.5 %id)
BU598457 mixed (pool of 40 RNAs) .j 239 to 969 1 to 729       729/806
(90 %)
9 diff
(98.9 %id)
BU633671 cell lines, Chondrosarcoma .j 242 to 971 749 to 19   AAA   731/731
(100 %)
1 diff
(99.9 %id)
CB528523 Aveolar Macrophage, lung .j 245 to 968 738 to 15   AAA   724/724
(100 %)
2 diff
(99.8 %id)
CA411913 Chondrosarcoma Grade II, Left Pelvis .j 262 to 971 728 to 19   AAA   710/710
(100 %)
0 diff
(100 %id)
BX443535.
matches multiple genes
T cells (Jurkat cell line) .j 263 to 970 1 to 708     also hits gene korsmey 708/708
(100 %)
0 diff
(100 %id)
BF516510   .j 263 to 777 530 to 16   AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 515/541
(95 %)
0 diff
(100 %id)
BU688113 lung .j 263 to 971 723 to 16   AAA   708/714
(99 %)
1 diff
(99.9 %id)
BU689496 lung, Primary Lung Cystic Fibrosis EpithelialCells .j 263 to 971 720 to 12   AAA   709/715
(99 %)
1 diff
(99.9 %id)
BU621205 cell lines, Chondrosarcoma .j 263 to 971 725 to 19   AAA   707/715
(98 %)
2 diff
(99.8 %id)
CA748653 Alveolar Macrophage, lung .j 263 to 971 726 to 19   AAA   708/716
(98 %)
1 diff
(99.9 %id)
CD370308 Alveolar Macrophage, lung .j 263 to 968 725 to 19   AAA   707/713
(99 %)
2 diff
(99.8 %id)
CA309511 Alveolar Macrophage, lung .j 267 to 971 719 to 19   AAA   701/705
(99 %)
6 diff
(99.2 %id)
BY994937   .j 276 to 964 698 to 10     Submitted on the opposite strand 689/698
(98 %)
0 diff
(100 %id)
CA944770 Human Lung Epithelial cells, lung .j 285 to 971 702 to 16   AAA   687/687
(100 %)
1 diff
(99.9 %id)
CD722677 eye, lacrimal gland .j 299 to 912 1 to 614       614/614
(100 %)
0 diff
(100 %id)
BG941753 blood .j 301 to 620 348 to 29   AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 320/322
(99 %)
0 diff
(100 %id)
CA306707 Alveolar Macrophage, lung .j 306 to 971 681 to 16   AAA   666/666
(100 %)
0 diff
(100 %id)
BM973652 lung .j 311 to 971 676 to 16   AAA   661/661
(100 %)
4 diff
(99.4 %id)
AA309712 aorta .j 325 to 666 1 to 341       341/341
(100 %)
3 diff
(99.2 %id)
BM973708 lung .j 325 to 971 662 to 16   AAA   647/647
(100 %)
0 diff
(100 %id)
BX395103 Neuroblastoma Cot 25-normalized .j 336 to 836 548 to 46   fully sequenced,   503/548
(91 %)
4 diff
(99.3 %id)
CA777519 Pancreas, Purified pancreatic islet .j 336 to 970 635 to 1   fully sequenced,   635/635
(100 %)
0 diff
(100 %id)
EB360740 eye, lens .j 345 to 972 640 to 14       627/640
(97 %)
1 diff
(99.9 %id)
BU581336 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .j 355 to 967 613 to 1       613/613
(100 %)
0 diff
(100 %id)
BF971153 adrenal cortex carcinoma, cell line, adrenal gland .j 358 to 946 1 to 586   AAA   586/627
(93 %)
11 diff
(98.3 %id)
BM450971 eye, retinoblastoma .j 363 to 928 1 to 568       568/871
(65 %)
5 diff
(99.5 %id)
TI_149284263   .j 365 to 968 688 to 84   AAA   605/803
(75 %)
3 diff
(99.7 %id)
BM740500 stomach .j 367 to 891 1 to 524       524/524
(100 %)
1 diff
(99.9 %id)
TI_149284480   .j 367 to 962 735 to 135       601/1242
(48 %)
14 diff
(98.9 %id)
AA214719   .j 378 to 761 1 to 393       393/393
(100 %)
18 diff
(95.5 %id)
BU680436 lung, Primary Lung Epithelial Cells .j 378 to 968 606 to 15   AAA   592/593
(99 %)
2 diff
(99.7 %id)
BM739539 stomach .j 396 to 940 1 to 543       543/543
(100 %)
3 diff
(99.5 %id)
W28003 eye, retina .j 411 to 723 8 to 321       314/539
(58 %)
12 diff
(97.8 %id)
CB136251 Liver .j 420 to 828 82 to 489       408/489
(83 %)
38 diff
(92.3 %id)
AA364309 pineal body .j 421 to 682 1 to 263       263/263
(100 %)
2 diff
(99.3 %id)
AW953806   .j 422 to 968 1 to 558       558/575
(97 %)
18 diff
(96.9 %id)
AA687553   .j 423 to 862 8 to 449       442/449
(98 %)
1 diff
(99.8 %id)
BP196464 adrenal gland .j 426 to 971 1 to 547   AAA   547/547
(100 %)
2 diff
(99.7 %id)
EH334104   .j 428 to 502 1 to 75       75/75
(100 %)
0 diff
(100 %id)
AI978624 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .j 429 to 967 540 to 2       539/540
(99 %)
0 diff
(100 %id)
TI_149291774   .j 430 to 971 633 to 90   AAA   544/696
(78 %)
2 diff
(99.8 %id)
BU682186 lung .j 430 to 971 559 to 16   AAA   544/559
(97 %)
2 diff
(99.7 %id)
BF111041 carcinoid, lung .j 434 to 930 1 to 497     Submitted on the opposite strand 497/497
(100 %)
1 diff
(99.8 %id)
AL519642 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .j 455 to 952 498 to 1   fully sequenced,   498/498
(100 %)
11 diff
(97.8 %id)
AI950951 breast, four pooled high-grade tumors, including twoprimary tumors and two metastatic to ovary .j 456 to 972 517 to 1       517/517
(100 %)
0 diff
(100 %id)
CR618403 B cells (Ramos cell line) Cot 25-normalized .k 1 to 1064 1 to 1064 exact tiling clone,   1064/1064
(100 %)
0 diff
(100 %id)
BX402034   .k 1 to 1064 1 to 1051 exact fully sequenced,   1051/1051
(100 %)
17 diff
(98.4 %id)
BX402033   .k 445 to 1046 602 to 1   fully sequenced,   602/602
(100 %)
1 diff
(99.9 %id)
BF213309 bone marrow, from acute myelogenous leukemia .l 1 to 674 1 to 663 W12G F13L G14A F15L G16A ... tiling clone,   663/751
(88 %)
19 diff
(97.5 %id)
AA035464 uterus .l 34 to 254 1 to 223   tiling clone,   223/223
(100 %)
2 diff
(99.2 %id)
BF440052 brain, glioblastoma (pooled) .l 226 to 890 665 to 1       665/665
(100 %)
5 diff
(99.3 %id)
CA431555 cell lines, Enchondroma .l 240 to 894 669 to 15   AAA   655/655
(100 %)
3 diff
(99.6 %id)
C00198   .l 268 to 620 1 to 359       359/369
(97 %)
10 diff
(97.3 %id)
AA127810 uterus .l 275 to 892 1 to 616   fully sequenced,   616/616
(100 %)
5 diff
(99.2 %id)
AA120782 uterus .l 275 to 517 1 to 250   fully sequenced,   250/250
(100 %)
0 diff
(100 %id)
BU948171 insulinoma, Pancreas .l 277 to 897 636 to 16   AAA   621/621
(100 %)
0 diff
(100 %id)
BQ300795 bladder_tumor .l 281 to 749 484 to 16       469/485
(96 %)
4 diff
(99.2 %id)
AA024761 heart .l 281 to 527 1 to 252   fully sequenced,   252/252
(100 %)
0 diff
(100 %id)
W76420 heart .l 284 to 598 1 to 316   fully sequenced,   316/316
(100 %)
0 diff
(100 %id)
CA420739 Bone, Enchondroma cell line .l 285 to 894 628 to 19   AAA   610/610
(100 %)
0 diff
(100 %id)
TI_159720619   .l 287 to 894 50 to 658   AAA Submitted on the opposite strand 609/658
(92 %)
6 diff
(99.1 %id)
BU628596 Bone, Enchondroma cell line .l 288 to 894 625 to 19   AAA   607/607
(100 %)
0 diff
(100 %id)
CB852926 Human Lung Epithelial cells, lung .l 289 to 894 1 to 607   AAA Submitted on the opposite strand 607/607
(100 %)
5 diff
(99.2 %id)
CA431019 cell lines, Chondrosarcoma .l 300 to 897 617 to 19   AAA   599/599
(100 %)
2 diff
(99.7 %id)
BM970124 lung .l 327 to 897 586 to 16   AAA   571/571
(100 %)
2 diff
(99.7 %id)
BU625679 cell lines, Enchondroma .l 331 to 897 585 to 19   AAA   567/567
(100 %)
0 diff
(100 %id)
AA639784 colon, colon tumor RER+ .l 333 to 894 561 to 1       561/561
(100 %)
1 diff
(99.9 %id)
CB157731 Liver .l 339 to 828 1 to 488       488/488
(100 %)
6 diff
(98.8 %id)
AA176320   .l 344 to 575 1 to 246   fully sequenced,   246/246
(100 %)
1 diff
(99.6 %id)
BF593734 brain, glioblastoma (pooled) .l 346 to 890 545 to 1       545/545
(100 %)
2 diff
(99.7 %id)
AI088520 uterus .l 350 to 897 548 to 1       548/548
(100 %)
0 diff
(100 %id)
AA035465 uterus .l 354 to 897 544 to 1       544/544
(100 %)
1 diff
(99.9 %id)
BP384583 pancreatic islet .l 355 to 855 1 to 501     Submitted on the opposite strand 501/501
(100 %)
3 diff
(99.5 %id)
AI719084 colon .l 361 to 890 530 to 1       530/530
(100 %)
2 diff
(99.7 %id)
AI984009 adenocarcinoma, Pancreas .l 361 to 898 542 to 4       539/542
(99 %)
0 diff
(100 %id)
BE675483 B-cell, chronic lymphotic leukemia .l 361 to 890 530 to 1       530/530
(100 %)
0 diff
(100 %id)
AI719711 colon .l 362 to 890 529 to 1       529/529
(100 %)
2 diff
(99.7 %id)
AW173349 pooled .l 369 to 897 529 to 1       529/538
(98 %)
2 diff
(99.7 %id)
AI453530 pooled .l 371 to 896 533 to 8       526/533
(98 %)
0 diff
(100 %id)
AA467792   .l 375 to 613 1 to 239       239/239
(100 %)
4 diff
(98.4 %id)
BM689864 eye, Retina Foveal and Macular .l 376 to 645 9 to 278   fully sequenced,   270/278
(97 %)
0 diff
(100 %id)
BE834190 ovary .l 380 to 773 14 to 404       391/410
(95 %)
6 diff
(98.6 %id)
BE877161 large cell carcinoma, undifferentiated, lung .l 381 to 897 12 to 526   AAA   515/526
(97 %)
6 diff
(98.9 %id)
BQ773674 Chondrosarcoma Grade II, Left Pelvis .l 382 to 897 534 to 19   AAA   516/525
(98 %)
0 diff
(100 %id)
N25654 melanocyte .l 383 to 897 521 to 1       521/521
(100 %)
14 diff
(97.4 %id)
AW390100 stomach .l 384 to 829 1 to 445       445/445
(100 %)
17 diff
(96.2 %id)
CB161661 Liver .l 393 to 766 220 to 593       374/593
(63 %)
6 diff
(99.0 %id)
AA643698 colon, colon tumor RER+ .l 394 to 894 501 to 1       501/501
(100 %)
0 diff
(100 %id)
BP391814 pancreatic islet .l 395 to 894 1 to 500     Submitted on the opposite strand 500/500
(100 %)
0 diff
(100 %id)
AA876647 metastatic prostate bone lesion .l 396 to 751 1 to 356       356/356
(100 %)
4 diff
(98.9 %id)
AI361959 brain, glioblastoma (pooled) .l 402 to 897 496 to 1       496/496
(100 %)
1 diff
(99.8 %id)
AW152523 serous papillary carcinoma, high grade, 2pooled tumors, uterus .l 402 to 898 498 to 2   tiling clone,   497/498
(99 %)
0 diff
(100 %id)
CA444577 lung, Metastatic Chondrosarcoma .l 402 to 894 507 to 15   AAA   493/493
(100 %)
1 diff
(99.8 %id)
BG656267 Pancreas, Purified pancreatic islet .l 404 to 895 491 to 1     Submitted on the opposite strand 491/491
(100 %)
6 diff
(98.8 %id)
AI954927 four pooled poorly-differentiatedadenocarcinomas, lung .l 406 to 897 492 to 1       492/492
(100 %)
1 diff
(99.8 %id)
AI342341 uterus .l 407 to 894 500 to 14   AAA   487/487
(100 %)
2 diff
(99.6 %id)
AI887169 serous papillary carcinoma, high grade, 2pooled tumors, uterus .l 407 to 897 491 to 1       491/491
(100 %)
1 diff
(99.8 %id)
AI336152 lung .l 408 to 898 492 to 2       491/492
(99 %)
0 diff
(100 %id)
AI953987 normal epithelium, ovary .l 408 to 898 492 to 2       491/492
(99 %)
0 diff
(100 %id)
AW051781 brain, glioblastoma (pooled) .l 408 to 882 483 to 9       475/483
(98 %)
0 diff
(100 %id)
AA088249 uterus .l 409 to 894 487 to 1       487/487
(100 %)
2 diff
(99.6 %id)
BF741937 bocio_tumor .l 411 to 734 326 to 3     Submitted on the opposite strand 324/326
(99 %)
0 diff
(100 %id)
AI142474 uterus .l 411 to 898 488 to 1       488/488
(100 %)
0 diff
(100 %id)
BU564013 mixed (pool of 40 RNAs) .l 415 to 896 1 to 485       485/771
(62 %)
8 diff
(99.0 %id)
N88793   .l 416 to 688 1 to 265       265/267
(99 %)
20 diff
(92.6 %id)
N56317   .l 417 to 697 1 to 280       280/282
(99 %)
2 diff
(99.3 %id)
AA922338 squamous cell carcinoma from base of tongue, tongue .l 427 to 895 469 to 1       469/469
(100 %)
1 diff
(99.8 %id)
AI609114 normal gingiva (cell line from immortalizedkeratinocytes) .l 427 to 894 468 to 1       468/471
(99 %)
0 diff
(100 %id)
BU536713 mixed (pool of 40 RNAs) .l 429 to 898 1 to 470       470/887
(52 %)
5 diff
(99.5 %id)
AI144474 heart .l 430 to 896 471 to 5       467/471
(99 %)
0 diff
(100 %id)
AI359968 anaplastic oligodendroglioma, brain .l 430 to 898 470 to 2       469/470
(99 %)
0 diff
(100 %id)
EB360867 eye, lens .l 431 to 898 517 to 50       468/518
(90 %)
0 diff
(100 %id)
BF939832 brain, glioblastoma (pooled) .l 434 to 885 457 to 6       452/457
(98 %)
0 diff
(100 %id)
AI040901 parathyroid gland, parathyroid tumor .l 436 to 896 469 to 8       462/469
(98 %)
0 diff
(100 %id)
AI143580 heart .l 436 to 898 463 to 1       463/463
(100 %)
2 diff
(99.6 %id)
BG054734 brain, glioblastoma (pooled) .l 436 to 890 455 to 1       455/455
(100 %)
1 diff
(99.8 %id)
BE300789 melanotic melanoma, skin .l 437 to 896 463 to 4       460/463
(99 %)
0 diff
(100 %id)
AI127719 uterus .l 440 to 896 459 to 3       457/459
(99 %)
0 diff
(100 %id)
GD143389   .l 443 to 547 1 to 105   AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 105/105
(100 %)
2 diff
(98.1 %id)
GD147319   .l 444 to 547 1 to 104   AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 104/104
(100 %)
3 diff
(97.2 %id)
AI493197 uterus .l 446 to 894 449 to 1       449/449
(100 %)
0 diff
(100 %id)
GD135862   .l 450 to 556 9 to 115       107/122
(87 %)
1 diff
(99.2 %id)
AA976499 Kidney, kidney tumor .l 450 to 894 447 to 1       447/447
(100 %)
4 diff
(99.2 %id)
AI337879 uterus .l 450 to 897 448 to 1       448/448
(100 %)
1 diff
(99.8 %id)
H84952 melanocyte .l 452 to 887 443 to 3       441/444
(99 %)
0 diff
(100 %id)
AI685961 Prostate .l 454 to 894 453 to 13   AAA   441/441
(100 %)
1 diff
(99.8 %id)
AA507014 breast .l 456 to 897 442 to 1       442/442
(100 %)
1 diff
(99.8 %id)
AI467977 pooled .l 460 to 896 441 to 5       437/441
(99 %)
0 diff
(100 %id)
DB535256 hippocampus .l 469 to 897 1 to 429     Submitted on the opposite strand 429/429
(100 %)
4 diff
(99.1 %id)
AA832498 carcinoid, lung .l 469 to 894 436 to 11   AAA   426/426
(100 %)
1 diff
(99.8 %id)
AI087247 senescent fibroblast .l 470 to 897 438 to 11   AAA   428/428
(100 %)
0 diff
(100 %id)
R99001 liver and spleen .l 472 to 894 437 to 1       437/444
(98 %)
21 diff
(95.3 %id)
N33152 melanocyte .l 472 to 893 430 to 6       425/430
(98 %)
0 diff
(100 %id)
AA865206 Kidney, kidney tumor .l 480 to 890 411 to 1       411/411
(100 %)
2 diff
(99.6 %id)
AW151050 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .l 482 to 898 420 to 4       417/420
(99 %)
0 diff
(100 %id)
AA723429 heart .l 483 to 896 409 to 1       409/409
(100 %)
6 diff
(98.6 %id)
AA830816 germinal center B cell .l 483 to 897 440 to 26   AAA   415/415
(100 %)
0 diff
(100 %id)
AA120783 uterus .l 487 to 894 408 to 1   fully sequenced,   408/408
(100 %)
2 diff
(99.6 %id)
AA910216 Kidney .l 489 to 897 409 to 1       409/409
(100 %)
1 diff
(99.8 %id)
EC507265 Prostate .l 490 to 599 108 to 1       108/108
(100 %)
2 diff
(98.2 %id)
BG254889 adenocarcinoma, cell line, Prostate .l 490 to 890 1 to 401   AAA   401/401
(100 %)
0 diff
(100 %id)
AI291251 carcinoid, lung .l 491 to 894 425 to 22   AAA   404/404
(100 %)
6 diff
(98.6 %id)
AI680538 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .l 495 to 897 402 to 1       402/402
(100 %)
1 diff
(99.8 %id)
AA024762 heart .l 497 to 894 398 to 1   fully sequenced,   398/398
(100 %)
1 diff
(99.8 %id)
N79707 multiple sclerosis lesions .l 498 to 898 1 to 405   fully sequenced,   405/405
(100 %)
6 diff
(98.6 %id)
AI302349 carcinoid, lung .l 498 to 896 400 to 2       399/400
(99 %)
0 diff
(100 %id)
AI188805 placenta .l 501 to 897 408 to 12   AAA   397/397
(100 %)
1 diff
(99.8 %id)
CB963376 Blood vessels - aorta, basilar and artery .l 504 to 898 1 to 395       395/409
(96 %)
2 diff
(99.6 %id)
CN288749 embryonic stem cells, DMSO-treated H9 cellline .l 509 to 898 1 to 390       390/392
(99 %)
2 diff
(99.5 %id)
R99236.
matches multiple genes
liver and spleen .l 510 to 897 407 to 15     also hits gene CNP 393/407
(96 %)
0 diff
(100 %id)
AA648271 germinal center B cell .l 510 to 897 398 to 11   AAA   388/388
(100 %)
2 diff
(99.5 %id)
AA974887 2 pooled tumors (clear cell type), Kidney .l 510 to 898 395 to 7       389/395
(98 %)
0 diff
(100 %id)
AI680260 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .l 510 to 894 385 to 1       385/386
(99 %)
2 diff
(99.5 %id)
AA505915 breast .l 512 to 894 383 to 1       383/383
(100 %)
0 diff
(100 %id)
AW337755 lymph node, lymphoma, follicular mixed small and largecell .l 513 to 896 384 to 1       384/384
(100 %)
0 diff
(100 %id)
AW304280 lung, two pooled squamous cell carcinomas .l 514 to 897 410 to 27   AAA   384/384
(100 %)
1 diff
(99.8 %id)
AA938653 2 pooled tumors (clear cell type), Kidney .l 520 to 897 378 to 1       378/378
(100 %)
1 diff
(99.8 %id)
AI190500 heart .l 520 to 898 383 to 5       379/383
(98 %)
0 diff
(100 %id)
AA857060 epithelium (cell line), Prostate .l 529 to 897 368 to 1       368/368
(100 %)
1 diff
(99.8 %id)
BG113179 Bone, osteosarcoma, cell line .l 534 to 890 1 to 358   AAA   358/358
(100 %)
4 diff
(98.9 %id)
AA176232   .l 545 to 898 354 to 1   fully sequenced,   354/354
(100 %)
1 diff
(99.8 %id)
AA121482 uterus .l 553 to 894 338 to 1   fully sequenced,   338/338
(100 %)
1 diff
(99.8 %id)
W72663 heart .l 568 to 898 332 to 1   fully sequenced,   332/332
(100 %)
4 diff
(98.8 %id)
BM661940 eye, Retina Foveal and Macular .l 615 to 897 298 to 16   fully sequenced, AAA   283/283
(100 %)
2 diff
(99.3 %id)
N62759 multiple sclerosis lesions .l 673 to 897 226 to 1   fully sequenced,   226/226
(100 %)
4 diff
(98.3 %id)
NM_001165258.1   .m 1 to 1179 1 to 1179 exact RefSeq, AAA   1179/1179
(100 %)
0 diff
(100 %id)
AL702149 human skeletal muscle .m 181 to 733 1 to 553 exact tiling clone,   553/553
(100 %)
1 diff
(99.9 %id)
FN054667 breast carcinoma .m 186 to 265 1 to 81       81/81
(100 %)
3 diff
(96.3 %id)
AA182911   .m 202 to 606 1 to 404       404/405
(99 %)
15 diff
(96.3 %id)
BX462877 fetal liver, Liver .m 216 to 926 1 to 712 Y17X Y81X A95X L98X P111X     712/712
(100 %)
13 diff
(98.2 %id)
BG944110 blood .m 223 to 646 1 to 424   tiling clone,   424/424
(100 %)
2 diff
(99.6 %id)
BI596754 brain, hypothalamus .m 272 to 1122 1 to 845 exact tiling clone,   845/845
(100 %)
20 diff
(97.7 %id)
TI_45208739   .m 277 to 1122 90 to 929 exact     840/929
(90 %)
21 diff
(97.8 %id)
CD627945   .m 338 to 742 16 to 420 exact     405/422
(95 %)
7 diff
(98.4 %id)
CD627946   .m 338 to 732 396 to 1 H112P     396/412
(96 %)
3 diff
(99.3 %id)
BF084806 denis_drash .m 341 to 733 15 to 410 Q2A D3G T4H G5M S6A ...     396/410
(96 %)
13 diff
(96.9 %id)
BG986065 denis_drash .m 341 to 733 15 to 410 Q2A D3G T4H G5M S6A ...     396/410
(96 %)
13 diff
(96.9 %id)
CV028280 mixed .m 386 to 723 1 to 338       338/520
(65 %)
1 diff
(99.9 %id)
N23533 melanocyte .m 386 to 841 1 to 463 F108X N109Q R110Q P111T H112P     463/464
(99 %)
9 diff
(98.1 %id)
AJ714044 bone marrow .m 441 to 765 1 to 325       325/325
(100 %)
2 diff
(99.4 %id)
CU445817 epidermis .m 441 to 772 1 to 332       332/344
(96 %)
8 diff
(97.7 %id)
CU447172 epidermis .m 441 to 772 1 to 332       332/344
(96 %)
10 diff
(97.1 %id)
CU447983 epidermis .m 441 to 772 1 to 332       332/344
(96 %)
8 diff
(97.7 %id)
CU450053 epidermis .m 441 to 772 1 to 332       332/344
(96 %)
8 diff
(97.7 %id)
CU452338 epidermis .m 441 to 772 1 to 332       332/344
(96 %)
8 diff
(97.7 %id)
CU453466 epidermis .m 441 to 772 1 to 332       332/344
(96 %)
8 diff
(97.7 %id)
CU453712 epidermis .m 441 to 772 1 to 332       332/344
(96 %)
10 diff
(97.1 %id)
CU455723 epidermis .m 441 to 772 1 to 332       332/344
(96 %)
9 diff
(97.4 %id)
CU443944 epidermis .m 443 to 772 342 to 13     Submitted on the opposite strand 330/344
(95 %)
5 diff
(98.6 %id)
CU444059 epidermis .m 443 to 772 342 to 13     Submitted on the opposite strand 330/344
(95 %)
5 diff
(98.6 %id)
CU444690 epidermis .m 443 to 772 342 to 13     Submitted on the opposite strand 330/344
(95 %)
5 diff
(98.6 %id)
CU446678 epidermis .m 443 to 772 342 to 13     Submitted on the opposite strand 330/344
(95 %)
5 diff
(98.6 %id)
CU446891 epidermis .m 443 to 772 342 to 13     Submitted on the opposite strand 330/344
(95 %)
5 diff
(98.6 %id)
CU453202 epidermis .m 443 to 772 342 to 13     Submitted on the opposite strand 330/344
(95 %)
5 diff
(98.6 %id)
CU454396 epidermis .m 443 to 772 342 to 13     Submitted on the opposite strand 330/344
(95 %)
5 diff
(98.6 %id)
CU455240 epidermis .m 443 to 772 342 to 13     Submitted on the opposite strand 330/344
(95 %)
5 diff
(98.6 %id)
CU455249 epidermis .m 443 to 772 342 to 13     Submitted on the opposite strand 330/344
(95 %)
5 diff
(98.6 %id)
CU455279 epidermis .m 443 to 772 342 to 13     Submitted on the opposite strand 330/344
(95 %)
6 diff
(98.3 %id)
CU455678 epidermis .m 443 to 772 342 to 13     Submitted on the opposite strand 330/344
(95 %)
5 diff
(98.6 %id)
CU456194 epidermis .m 443 to 772 342 to 13     Submitted on the opposite strand 330/344
(95 %)
5 diff
(98.6 %id)
CU447441 epidermis .m 450 to 772 10 to 332       323/344
(93 %)
7 diff
(98.0 %id)
R07414 liver and spleen .m 454 to 817 8 to 376       369/376
(98 %)
13 diff
(96.6 %id)
AA181577   .m 750 to 1187 441 to 3   tiling clone,   439/441
(99 %)
0 diff
(100 %id)
BG483497 lung .n 1 to 591 4 to 599   tiling clone,   599/635
(94 %)
16 diff
(97.5 %id)
AA364785 pineal body .n 500 to 743 1 to 244   tiling clone,   244/244
(100 %)
0 diff
(100 %id)
EC555378 Prostate .n 501 to 595 95 to 4       92/95
(96 %)
2 diff
(97.9 %id)
FN067559 breast carcinoma .n 524 to 605 1 to 80       80/80
(100 %)
3 diff
(96.3 %id)
CU448441 epidermis .n 539 to 714 189 to 13     Submitted on the opposite strand 177/197
(89 %)
6 diff
(97.0 %id)
CU452194 epidermis .n 539 to 714 189 to 13     Submitted on the opposite strand 177/197
(89 %)
6 diff
(97.0 %id)
CU452513 epidermis .n 539 to 714 189 to 13     Submitted on the opposite strand 177/197
(89 %)
6 diff
(97.0 %id)
CU456228 epidermis .n 539 to 714 189 to 13     Submitted on the opposite strand 177/197
(89 %)
6 diff
(97.0 %id)
CU456768 epidermis .n 539 to 714 189 to 13     Submitted on the opposite strand 177/197
(89 %)
6 diff
(97.0 %id)
CX784985 human embryonic stem cells .o 1 to 760 1 to 760 exact tiling clone,   760/760
(100 %)
1 diff
(99.9 %id)
NM_016462.3   .o 1 to 1165 1 to 1165 exact RefSeq, AAA   1165/1165
(100 %)
0 diff
(100 %id)
R20300 whole brain .o 61 to 532 9 to 481       473/481
(98 %)
15 diff
(96.9 %id)
DA733637   .o 73 to 689 2 to 616   fully sequenced, capped   615/615
(100 %)
5 diff
(99.2 %id)
CR621789 Placenta Cot 25-normalized .o 147 to 1171 1 to 1025 exact     1025/1025
(100 %)
0 diff
(100 %id)
DT219607 brain .o 152 to 781 1 to 630 exact     630/630
(100 %)
5 diff
(99.3 %id)
BM761536 myeloma .o 156 to 698 1 to 544       544/544
(100 %)
2 diff
(99.7 %id)
BM821418 stomach .o 157 to 647 1 to 492       492/492
(100 %)
2 diff
(99.6 %id)
BP218115 caudate nucleus .o 164 to 745 1 to 582 V62G V103G     582/582
(100 %)
6 diff
(99.0 %id)
BX361009 Placenta Cot 25-normalized .o 168 to 1168 1 to 993 exact fully sequenced,   993/993
(100 %)
16 diff
(98.4 %id)
AW160399 brain, frontal lobe .o 168 to 673 1 to 506   fully sequenced,   506/506
(100 %)
0 diff
(100 %id)
CN362734 embryonic stem cells, DMSO-treated H9 cellline .o 170 to 628 1 to 459       459/459
(100 %)
6 diff
(98.7 %id)
BM821101 stomach .o 170 to 624 12 to 466       455/466
(97 %)
6 diff
(98.8 %id)
CR626492 Neuroblastoma Cot 25-normalized .o 171 to 1160 1 to 990 exact     990/990
(100 %)
0 diff
(100 %id)
AL527781 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .o 171 to 1158 1 to 981 Q2P T4P H11P I26L I27L ... fully sequenced,   981/981
(100 %)
41 diff
(95.9 %id)
CN362731 embryonic stem cells, DMSO-treated H9 cellline .o 172 to 668 1 to 497       497/497
(100 %)
3 diff
(99.4 %id)
BF725812 eye, Iris .o 174 to 752 1 to 579 exact     579/579
(100 %)
0 diff
(100 %id)
CR608848 Placenta Cot 25-normalized .o 174 to 1170 1 to 997 exact     997/997
(100 %)
0 diff
(100 %id)
BX381354 Placenta Cot 25-normalized .o 174 to 1164 1 to 987 exact fully sequenced,   987/987
(100 %)
9 diff
(99.1 %id)
CD691969 normal nasopharynx .o 175 to 636 17 to 480       464/480
(96 %)
10 diff
(98.0 %id)
AW175673 breast .o 178 to 365 205 to 18       188/205
(91 %)
0 diff
(100 %id)
CN362729 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .o 179 to 705 1 to 527       527/527
(100 %)
0 diff
(100 %id)
AV725874 hypothalamus .o 181 to 613 1 to 379       379/380
(99 %)
2 diff
(99.5 %id)
BP290276 lung .o 181 to 765 1 to 584 N61T V62F W63G V64F F65S ...     584/584
(100 %)
1 diff
(99.9 %id)
BE732828 choriocarcinoma, placenta .o 186 to 932 1 to 743 exact     743/1031
(72 %)
9 diff
(99.2 %id)
TI_154194363   .o 186 to 1064 48 to 916 exact     869/1010
(86 %)
45 diff
(95.6 %id)
BE736231 adenocarcinoma, Pancreas .o 187 to 822 1 to 639 S34K V35R P36A S37V L38P ... AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 639/639
(100 %)
7 diff
(99.0 %id)
BI906388 leukocyte .o 187 to 1109 1 to 927 exact     927/928
(99 %)
23 diff
(97.6 %id)
CF128476 Chondrosarcoma Lung Metastasis cell lines, lung .o 187 to 835 1 to 649 exact     649/649
(100 %)
7 diff
(99.0 %id)
TI_57232319   .o 187 to 1109 27 to 953 exact     927/954
(97 %)
28 diff
(97.1 %id)
DB486907 hypothalamus .o 188 to 634 1 to 447       447/447
(100 %)
8 diff
(98.3 %id)
BG577270 breast, mammary adenocarcinoma, cell line .o 188 to 1104 1 to 915 G33R S34Q V35R P36A S37V ...     915/919
(99 %)
27 diff
(97.1 %id)
AF151028 umbilical cord blood .o 191 to 1165 1 to 975 exact AAA   975/975
(100 %)
3 diff
(99.7 %id)
BX337084 Placenta Cot 25-normalized .o 191 to 1127 1 to 930 S56X M78X F108S AAA   930/963
(96 %)
21 diff
(97.9 %id)
N34255 melanocyte .o 191 to 709 1 to 519       519/521
(99 %)
4 diff
(99.3 %id)
H79944 melanocyte .o 193 to 628 1 to 447       447/452
(98 %)
16 diff
(96.5 %id)
BU197365 eye, retinoblastoma .o 193 to 994 1 to 804 exact     804/805
(99 %)
7 diff
(99.2 %id)
BU072831 Pancreas, Purified pancreatic islet .o 196 to 689 1 to 494   fully sequenced,   494/494
(100 %)
2 diff
(99.6 %id)
BM925858 brain .o 197 to 948 9 to 764 exact     756/1166
(64 %)
23 diff
(98.1 %id)
BU541140 carcinoma, cell line, Prostate .o 197 to 1029 1 to 837 exact     837/893
(93 %)
11 diff
(98.8 %id)
BU543180 carcinoma, cell line, Prostate .o 197 to 1084 1 to 887 exact     887/889
(99 %)
9 diff
(99.0 %id)
BM511154 insulinoma, Pancreas .o 200 to 601 8 to 409   fully sequenced,   402/409
(98 %)
6 diff
(98.6 %id)
BM876625 insulinoma, Pancreas .o 200 to 689 8 to 498   fully sequenced,   491/498
(98 %)
7 diff
(98.6 %id)
BQ130427 insulinoma, Pancreas .o 200 to 601 8 to 409   fully sequenced,   402/409
(98 %)
6 diff
(98.6 %id)
BQ267514 insulinoma, Pancreas .o 200 to 689 8 to 497   fully sequenced,   490/497
(98 %)
6 diff
(98.8 %id)
BU782091 insulinoma, Pancreas .o 200 to 601 8 to 409   fully sequenced,   402/409
(98 %)
6 diff
(98.6 %id)
BU787900 insulinoma, Pancreas .o 200 to 773 8 to 582 I75X M76Y M78N R79E F80V ... fully sequenced,   575/582
(98 %)
7 diff
(98.8 %id)
BU947257 insulinoma, Pancreas .o 200 to 601 8 to 409   fully sequenced,   402/409
(98 %)
6 diff
(98.6 %id)
BU947943 insulinoma, Pancreas .o 200 to 601 8 to 409   fully sequenced,   402/409
(98 %)
6 diff
(98.6 %id)
CN362728 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .o 202 to 632 1 to 431       431/431
(100 %)
0 diff
(100 %id)
CB159201 Liver .o 202 to 767 1 to 566 exact     566/566
(100 %)
0 diff
(100 %id)
AA132425   .o 205 to 609 1 to 406       406/406
(100 %)
15 diff
(96.4 %id)
BU601204 mixed (pool of 40 RNAs) .o 206 to 941 1 to 739 K85N F86S M87C P88L A89Q ...     739/865
(85 %)
32 diff
(96.4 %id)
DR005029 placenta .o 209 to 974 1 to 765 exact     765/765
(100 %)
5 diff
(99.4 %id)
DN990664 brain, whole brain .o 210 to 815 8 to 613 exact     606/613
(98 %)
6 diff
(99.1 %id)
BI862483 breast, mammary adenocarcinoma, cell line .o 211 to 1107 1 to 905 exact     905/905
(100 %)
20 diff
(97.8 %id)
TI_57192659   .o 211 to 1107 91 to 995 exact     905/905
(100 %)
20 diff
(97.8 %id)
BG396810 eye, retinoblastoma .o 212 to 790 1 to 579 exact     579/579
(100 %)
2 diff
(99.7 %id)
BQ269976 Pancreas, Purified pancreatic islet .o 215 to 689 1 to 475   fully sequenced,   475/475
(100 %)
0 diff
(100 %id)
CD242944 brain, Pituitary .o 215 to 960 18 to 768 exact     751/914
(82 %)
16 diff
(98.3 %id)
BM016434 breast, mammary adenocarcinoma, cell line .o 216 to 1072 1 to 854 W12G F13L G14A F15L G16A ...     854/883
(96 %)
29 diff
(96.8 %id)
CF128858 Chondrosarcoma Lung Metastasis cell lines, lung .o 216 to 824 1 to 609 exact     609/609
(100 %)
1 diff
(99.9 %id)
TI_59393364   .o 216 to 1072 91 to 944 W12G F13L G14A F15L G16A ...     854/883
(96 %)
29 diff
(96.8 %id)
BP318643 pericardium .o 216 to 807 1 to 592 exact     592/592
(100 %)
1 diff
(99.9 %id)
TI_154188994   .o 216 to 1173 39 to 984 exact     946/1021
(92 %)
41 diff
(96.0 %id)
BU538324 adenocarcinoma, cell line, breast .o 218 to 1103 1 to 891 exact     891/958
(93 %)
20 diff
(98.0 %id)
DB468081 hippocampus .o 219 to 646 1 to 429       429/429
(100 %)
5 diff
(98.9 %id)
BE781977 eye, retinoblastoma .o 220 to 954 1 to 728 exact     728/1104
(65 %)
10 diff
(99.1 %id)
TI_57170099   .o 220 to 1117 87 to 978 Y29X V30*     892/979
(91 %)
31 diff
(96.9 %id)
BG419250 Kidney, renal cell adenocarcinoma .o 223 to 946 1 to 723 exact     723/1027
(70 %)
20 diff
(98.1 %id)
BF026407 melanotic melanoma, skin .o 228 to 949 1 to 721 exact     721/1099
(65 %)
15 diff
(98.7 %id)
BF684507 leiomyosarcoma cell line, uterus .o 228 to 954 1 to 729 exact     729/952
(76 %)
17 diff
(98.3 %id)
BI825217 brain, medulla .o 228 to 1117 1 to 884 Y29X V30*     884/885
(99 %)
25 diff
(97.2 %id)
BU948332 insulinoma, Pancreas .o 228 to 827 8 to 607 exact     600/607
(98 %)
7 diff
(98.9 %id)
CA393423 eye, RPE/choroid .o 229 to 742 7 to 520 exact     514/520
(98 %)
6 diff
(98.9 %id)
BU173096 eye, retinoblastoma .o 233 to 1110 1 to 881 exact     881/882
(99 %)
11 diff
(98.8 %id)
BQ695359 adipose .o 235 to 460 1 to 227       227/227
(100 %)
3 diff
(98.7 %id)
CN362730 embryonic stem cells, DMSO-treated H9 cellline .o 235 to 570 1 to 336       336/336
(100 %)
0 diff
(100 %id)
BG614987 embryonal carcinoma, testis .o 235 to 829 1 to 597 W63G V64F F65S L66*     597/599
(99 %)
12 diff
(98.0 %id)
CF126202 Chondrosarcoma Lung Metastasis cell lines, lung .o 235 to 976 1 to 742 exact     742/742
(100 %)
3 diff
(99.6 %id)
TI_154189161   .o 235 to 1028 40 to 833 exact     794/1030
(77 %)
8 diff
(99.3 %id)
BC010086 Placenta, choriocarcinoma .o 237 to 1165 1 to 929 exact available from MGC, AAA   929/929
(100 %)
0 diff
(100 %id)
BM559147 amelanotic melanoma, cell line, skin .o 238 to 1110 1 to 881 exact     881/1033
(85 %)
19 diff
(98.2 %id)
H73299 liver and spleen .o 239 to 570 1 to 339       339/405
(83 %)
11 diff
(97.3 %id)
BM915785 amelanotic melanoma, cell line, skin .o 239 to 1173 1 to 941 exact     941/1041
(90 %)
29 diff
(97.3 %id)
BM916648 amelanotic melanoma, cell line, skin .o 239 to 936 1 to 703 exact     703/1211
(58 %)
22 diff
(98.2 %id)
CN362733 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .o 241 to 767 1 to 527 exact     527/527
(100 %)
0 diff
(100 %id)
BG750959 eye, normal pigmented retinal epithelium .o 241 to 1116 1 to 871 exact     871/871
(100 %)
33 diff
(96.3 %id)
CN362735 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .o 242 to 453 1 to 212       212/212
(100 %)
0 diff
(100 %id)
TI_57215676   .o 243 to 1108 21 to 881 exact     861/881
(97 %)
13 diff
(98.6 %id)
BE513040 adenocarcinoma cell line, colon .o 248 to 876 1 to 636 exact     636/640
(99 %)
11 diff
(98.3 %id)
BG715886 brain, hypothalamus .o 248 to 939 1 to 690 S6*     690/694
(99 %)
9 diff
(98.8 %id)
BI551230 brain, hippocampus .o 249 to 1139 1 to 883 exact     883/943
(93 %)
41 diff
(95.7 %id)
CD048107 embryonic stem cells, WA01, passage 38 .o 252 to 1151 23 to 927 exact     905/948
(95 %)
17 diff
(98.3 %id)
CD696404 normal nasopharynx .o 252 to 766 23 to 537 exact     515/537
(95 %)
7 diff
(98.7 %id)
BG254402 adenocarcinoma, cell line, Prostate .o 252 to 740 1 to 490 K102N     490/942
(52 %)
3 diff
(99.7 %id)
BI755167 brain .o 252 to 1108 1 to 852 exact     852/852
(100 %)
8 diff
(99.1 %id)
BQ721276 sympathetic trunk .o 252 to 1125 5 to 902 exact     898/944
(95 %)
65 diff
(93.2 %id)
BP294758   .o 253 to 857 1 to 605 T71A     605/605
(100 %)
4 diff
(99.4 %id)
BP320700 placenta .o 253 to 834 1 to 582 exact     582/582
(100 %)
2 diff
(99.7 %id)
CD048027 embryonic stem cells, WA01, passage 38 .o 254 to 1125 21 to 900 exact     880/920
(95 %)
23 diff
(97.5 %id)
CR608762 Neuroblastoma Cot 10-normalized .o 254 to 1171 1 to 918 exact     918/918
(100 %)
0 diff
(100 %id)
AL519895 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .o 254 to 1171 1 to 918 exact     918/918
(100 %)
4 diff
(99.6 %id)
BX364226   .o 254 to 1173 1 to 917 exact     917/917
(100 %)
7 diff
(99.3 %id)
CB177191 Pancreas, Purified pancreatic islet .o 254 to 731 1 to 476 exact fully sequenced,   476/476
(100 %)
0 diff
(100 %id)
TI_44171353   .o 254 to 1139 93 to 970 exact     878/1030
(85 %)
43 diff
(95.9 %id)
BP270435 small intestine .o 254 to 835 1 to 582 exact     582/582
(100 %)
0 diff
(100 %id)
BP322786 Pancreas .o 254 to 837 1 to 584 A19S     584/584
(100 %)
2 diff
(99.7 %id)
CD248644 embryonic stem cells, WA01, passage 38 .o 255 to 1084 16 to 847 exact     832/888
(93 %)
14 diff
(98.5 %id)
CN362732 embryonic stem cells, DMSO-treated H9 cellline .o 255 to 670 1 to 416       416/416
(100 %)
3 diff
(99.3 %id)
BP317167 pericardium .o 256 to 837 1 to 582 exact     582/582
(100 %)
0 diff
(100 %id)
BM766043 stomach .o 256 to 832 1 to 577 exact     577/577
(100 %)
1 diff
(99.9 %id)
AW239079 lung, cell line .o 257 to 689 1 to 433       433/433
(100 %)
0 diff
(100 %id)
BE780848 eye, retinoblastoma .o 258 to 956 16 to 708 W63G V64F F65S L66*     693/759
(91 %)
24 diff
(96.9 %id)
BG715919 brain, hypothalamus .o 258 to 949 1 to 691 L72*     691/692
(99 %)
8 diff
(98.9 %id)
CR626312 B cells (Ramos cell line) Cot 25-normalized .o 259 to 1170 1 to 912 exact     912/912
(100 %)
0 diff
(100 %id)
CR736659 senescent fibroblast .o 259 to 954 1 to 696 exact     696/699
(99 %)
1 diff
(99.9 %id)
AL561106 B cells from Burkitt lymphoma .o 259 to 1170 1 to 914 Q54X P59X fully sequenced,   914/914
(100 %)
18 diff
(98.1 %id)
BG703251 brain, hippocampus .o 259 to 1017 1 to 758 exact     758/758
(100 %)
7 diff
(99.1 %id)
BQ439527 large cell carcinoma, lung .o 259 to 1123 1 to 865 exact     865/866
(99 %)
6 diff
(99.4 %id)
TI_44170282   .o 259 to 1107 78 to 926 exact     849/926
(91 %)
15 diff
(98.4 %id)
BM785187 myeloma .o 261 to 871 1 to 611 exact     611/611
(100 %)
4 diff
(99.4 %id)
BM781962 myeloma .o 261 to 870 1 to 610 exact     610/610
(100 %)
4 diff
(99.4 %id)
BG831195 epithelioid carcinoma cell line, Pancreas .o 262 to 1035 1 to 779 A67D T68Y S69I G70W T71Y ...     779/780
(99 %)
13 diff
(98.4 %id)
BE563797 adenocarcinoma, Pancreas .o 263 to 1061 11 to 802 L10C H11M W12V F13G G14F ...     792/901
(87 %)
38 diff
(95.8 %id)
BG476583 melanotic melanoma, skin .o 264 to 1026 1 to 769 exact     769/769
(100 %)
15 diff
(98.1 %id)
BG105762 adrenal cortex carcinoma, cell line, adrenal gland .o 265 to 947 1 to 697 exact     697/868
(80 %)
15 diff
(98.3 %id)
BG681183 skin, squamous cell carcinoma .o 265 to 1116 1 to 861 exact     861/862
(99 %)
18 diff
(98.0 %id)
BC002496 Skin, melanotic melanoma. .o 266 to 1165 1 to 900 exact available from MGC, AAA   900/900
(100 %)
0 diff
(100 %id)
BE387517 melanotic melanoma, skin .o 266 to 943 12 to 691 exact     680/692
(98 %)
9 diff
(98.7 %id)
BE778881 eye, retinoblastoma .o 266 to 949 1 to 689 L55H S56V Q57S D58G P59S ...     689/1067
(64 %)
17 diff
(98.5 %id)
BI553445 brain, hippocampus .o 266 to 1107 1 to 842 exact     842/842
(100 %)
12 diff
(98.6 %id)
BG281396 melanotic melanoma, skin .o 267 to 1151 1 to 874 I27X     874/894
(97 %)
24 diff
(97.4 %id)
BM711023 eye, fetal eyes .o 267 to 727 1 to 461 exact fully sequenced,   461/461
(100 %)
1 diff
(99.8 %id)
CK430578 eye, lacrimal gland .o 268 to 892 1 to 625 exact     625/625
(100 %)
0 diff
(100 %id)
CR602451 Placenta Cot 25-normalized .o 269 to 1173 1 to 905 exact tiling clone,   905/905
(100 %)
0 diff
(100 %id)
BX379225 Placenta Cot 25-normalized .o 269 to 1173 1 to 905 exact fully sequenced,   905/905
(100 %)
2 diff
(99.8 %id)
W19497 lung .o 269 to 658 1 to 390       390/392
(99 %)
12 diff
(97.0 %id)
BE390815 endometrium, adenocarcinoma cell line, uterus .o 269 to 930 1 to 659 exact     659/683
(96 %)
9 diff
(98.7 %id)
TI_57216702   .o 269 to 1109 34 to 873 exact     840/874
(96 %)
12 diff
(98.7 %id)
R97376 liver and spleen .o 270 to 658 1 to 391       391/459
(85 %)
5 diff
(99.0 %id)
BI756751 brain .o 270 to 1109 1 to 839 exact     839/840
(99 %)
7 diff
(99.2 %id)
BM475293 eye, retinoblastoma .o 270 to 960 1 to 705 exact     705/1208
(58 %)
28 diff
(97.7 %id)
CF454595 peripheral nervous system .o 270 to 1075 1 to 800 exact     800/905
(88 %)
16 diff
(98.3 %id)
CD513974 brain, Pituitary .o 273 to 883 8 to 628 exact     621/1060
(58 %)
21 diff
(98.1 %id)
BF239121 bone marrow, from chronic myelogenous leukemia .o 276 to 761 1 to 486 exact     486/486
(100 %)
2 diff
(99.6 %id)
BP196207 adrenal gland .o 277 to 857 1 to 581 exact     581/581
(100 %)
0 diff
(100 %id)
BF036674 adenocarcinoma, ovary .o 278 to 962 1 to 675 W12G F13W G14L F15W G16L ...     675/893
(75 %)
19 diff
(97.9 %id)
BF667921 brain, primitive neuroectoderm .o 279 to 860 1 to 583 exact     583/661
(88 %)
9 diff
(98.7 %id)
CB217445 mandible, pooled .o 279 to 809 1 to 531 exact fully sequenced,   531/531
(100 %)
1 diff
(99.9 %id)
W07289 lung .o 280 to 498 1 to 222       222/224
(99 %)
9 diff
(96.0 %id)
BE878075 large cell carcinoma, undifferentiated, lung .o 280 to 959 1 to 678 exact     678/688
(98 %)
11 diff
(98.5 %id)
BM542243 melanotic melanoma, skin .o 280 to 1152 1 to 875 G41R     875/986
(88 %)
17 diff
(98.3 %id)
CD106536 brain, Pituitary .o 281 to 1078 1 to 800 exact     800/800
(100 %)
10 diff
(98.8 %id)
BF681153 Prostate .o 282 to 932 1 to 649 H11Q W12L F13V G14W F15L ...     649/854
(75 %)
21 diff
(97.6 %id)
AV751872 Pituitary .o 283 to 792 1 to 504 V7R G94S G104E V105L F108S ...     504/513
(98 %)
20 diff
(96.2 %id)
AW407963 lymph .o 284 to 681 1 to 399   fully sequenced,   397/397
(100 %)
6 diff
(98.5 %id)
AA302225 aorta .o 285 to 677 1 to 400       400/400
(100 %)
9 diff
(97.8 %id)
BE276608 melanotic melanoma, skin .o 285 to 727 1 to 443 exact     443/445
(99 %)
1 diff
(99.8 %id)
BM127107 Islets of Langerhans, Pancreas .o 285 to 770 1 to 486 exact fully sequenced,   486/486
(100 %)
0 diff
(100 %id)
BE782483 eye, retinoblastoma .o 286 to 1016 1 to 712 W63G V64F F65S L66*     712/886
(80 %)
11 diff
(98.8 %id)
BE779179 eye, retinoblastoma .o 287 to 913 1 to 628 exact     628/878
(71 %)
21 diff
(97.7 %id)
CR594179 Placenta Cot 25-normalized .o 288 to 1141 1 to 854 exact     854/854
(100 %)
0 diff
(100 %id)
EL955013 eyeball .o 288 to 799 1 to 507 Q2T D3W T4L G5S V7A ...     507/507
(100 %)
15 diff
(97.1 %id)
H70394 liver and spleen .o 290 to 743 1 to 459 S37Y L38P A39G A40C G41R ...     459/464
(98 %)
14 diff
(97.0 %id)
BQ271333 Pancreas, Purified pancreatic islet .o 290 to 689 1 to 400   fully sequenced, AAA   400/400
(100 %)
1 diff
(99.8 %id)
TI_154146125   .o 290 to 843 77 to 629 G33S A48S A67X P88L G90C ...     553/835
(66 %)
30 diff
(96.5 %id)
TI_154147086   .o 290 to 847 79 to 650 S96N L97F L98A M99D V100G ...     570/650
(87 %)
30 diff
(95.4 %id)
BG655952 Pancreas, Purified pancreatic islet .o 291 to 703 4 to 414       411/414
(99 %)
21 diff
(95.0 %id)
W52852 Pancreas, pancreatic islet .o 293 to 816 1 to 527 Q54X L55A S56V Q57S D58R ... fully sequenced,   525/525
(100 %)
4 diff
(99.3 %id)
CB986635 Pooled-Glandular .o 297 to 788 1 to 498 exact     498/988
(50 %)
20 diff
(98.0 %id)
BF679234 Prostate .o 299 to 839 1 to 540 exact     540/540
(100 %)
4 diff
(99.3 %id)
BU942621 mixed (pool of 40 RNAs) .o 299 to 1086 1 to 790 exact     790/790
(100 %)
15 diff
(98.2 %id)
BU963760 mixed (pool of 40 RNAs) .o 299 to 1061 1 to 770 exact     770/770
(100 %)
10 diff
(98.8 %id)
TI_154193006   .o 300 to 1120 50 to 861 R110T     812/977
(83 %)
15 diff
(98.5 %id)
CF130868 Chondrosarcoma Lung Metastasis cell lines, lung .o 301 to 982 1 to 682 R110T     682/682
(100 %)
3 diff
(99.6 %id)
AK223462 Pancreas .o 303 to 817 1 to 515 A19S     515/515
(100 %)
1 diff
(99.9 %id)
N30499 melanocyte .o 306 to 795 1 to 495 V100X fully sequenced,   495/495
(100 %)
9 diff
(98.2 %id)
BG925535 cartilage .o 307 to 913 86 to 692 exact     607/623
(97 %)
6 diff
(99.1 %id)
BG574400 breast, mammary adenocarcinoma, cell line .o 309 to 1027 14 to 733 exact     720/733
(98 %)
9 diff
(98.8 %id)
T70776 liver and spleen .o 311 to 658 1 to 355       355/356
(99 %)
10 diff
(97.2 %id)
W31972 parathyroid gland, parathyroid tumor .o 319 to 718 13 to 426 R79K F80V Y81L H82P S83L ...     384/426
(90 %)
11 diff
(97.5 %id)
BE960859 melanotic melanoma, high MDR, skin .o 320 to 960 1 to 633 W12G F13W G14L F15W G16L ...     633/806
(78 %)
20 diff
(97.6 %id)
CA950453 Pancreas, Purified pancreatic islet .o 323 to 572 1 to 252       252/289
(87 %)
16 diff
(94.5 %id)
CR593270 Placenta Cot 25-normalized .o 327 to 1173 1 to 847 exact     847/847
(100 %)
0 diff
(100 %id)
CR625322 T cells (Jurkat cell line) .o 327 to 1146 1 to 820 exact     820/820
(100 %)
0 diff
(100 %id)
BX424357 T cells (Jurkat cell line) .o 327 to 1164 1 to 838 N61X V62R W63L V64G L66P ...     838/845
(99 %)
16 diff
(98.2 %id)
AL557695 T cells (Jurkat cell line), T cells from T cell leukemia .o 327 to 601 1 to 275   fully sequenced,   275/275
(100 %)
0 diff
(100 %id)
BX379296 Placenta Cot 25-normalized .o 327 to 1173 1 to 848 exact fully sequenced,   848/848
(100 %)
3 diff
(99.7 %id)
TI_149287950   .o 327 to 1172 918 to 75 P9L L10C H11I W12G F13W ... AAA   844/1064
(79 %)
23 diff
(97.9 %id)
BG392328 embryonal carcinoma, cell line, testis .o 330 to 1120 1 to 784 exact     784/784
(100 %)
11 diff
(98.6 %id)
CA777029.
matches multiple genes
Pancreas, Purified pancreatic islet .o 330 to 908 13 to 591 exact   also hits gene korsmey 579/591
(97 %)
7 diff
(98.9 %id)
AF164962 normal aorta .o 331 to 942 75 to 687 L55A S56V Q57S D58G P59S ... AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 613/687
(89 %)
15 diff
(97.9 %id)
BM688613 eye, eye anterior segment .o 359 to 708 1 to 350       350/350
(100 %)
5 diff
(98.6 %id)
DR422938 eye, Pterygium .o 366 to 1103 1 to 738 exact     738/738
(100 %)
3 diff
(99.6 %id)
BG033941 breast, mammary adenocarcinoma, cell line .o 380 to 1133 1 to 751       751/795
(94 %)
12 diff
(98.5 %id)
TI_154061656   .o 388 to 1169 872 to 96   AAA   777/974
(79 %)
13 diff
(98.7 %id)
TI_154110242   .o 388 to 1172 843 to 61   AAA   783/967
(80 %)
12 diff
(98.8 %id)
TI_159722832   .o 388 to 1169 856 to 78   AAA   779/1012
(76 %)
10 diff
(99.1 %id)
BU532132 mixed (pool of 40 RNAs) .o 391 to 824 1 to 434       434/438
(99 %)
2 diff
(99.6 %id)
BX462876 fetal liver, Liver .o 392 to 1142 752 to 1       751/752
(99 %)
33 diff
(95.7 %id)
CN362727 embryonic stem cells, cell lines H1, H7, andH9 .o 394 to 989 1 to 596       596/596
(100 %)
0 diff
(100 %id)
BM689529 eye, Retina Foveal and Macular .o 398 to 689 9 to 300   fully sequenced,   292/300
(97 %)
6 diff
(98.0 %id)
BQ007519 Chondrosarcoma, Left Pubic Bone .o 409 to 1172 775 to 16   AAA   760/766
(99 %)
4 diff
(99.5 %id)
W80575 heart .o 411 to 762 1 to 361   fully sequenced,   361/361
(100 %)
10 diff
(97.3 %id)
TI_149297235   .o 412 to 1169 839 to 83   AAA   757/950
(79 %)
4 diff
(99.6 %id)
BU169969 large cell carcinoma, lung .o 413 to 1169 1 to 757   AAA   757/757
(100 %)
6 diff
(99.3 %id)
BU623774 cell lines, Enchondroma .o 413 to 1169 773 to 19   AAA   755/755
(100 %)
2 diff
(99.8 %id)
CB853134 Human Lung Epithelial cells, lung .o 425 to 1169 757 to 15   AAA   743/743
(100 %)
4 diff
(99.5 %id)
BE778879 eye, retinoblastoma .o 427 to 1171 1 to 733       733/908
(80 %)
29 diff
(96.9 %id)
BQ771935 Chondrosarcoma Grade II, Left Pelvis .o 434 to 1172 754 to 19   AAA   736/736
(100 %)
11 diff
(98.6 %id)
BM982337 lung, Primary Lung Cystic Fibrosis EpithelialCells .o 435 to 1169 749 to 15   AAA   735/735
(100 %)
1 diff
(99.9 %id)
BY800425 eye .o 438 to 1034 1 to 597       597/597
(100 %)
1 diff
(99.9 %id)
TI_151715788   .o 444 to 1172 853 to 122   AAA   699/855
(81 %)
26 diff
(97.0 %id)
AA455701 germinal center B cell .o 445 to 881 1 to 437   fully sequenced,   437/437
(100 %)
9 diff
(98.0 %id)
BM700003 eye, lens .o 445 to 995 1 to 553       553/558
(99 %)
3 diff
(99.5 %id)
BG284263 adenocarcinoma, cell line, Prostate .o 448 to 1171 1 to 722   AAA   722/730
(98 %)
11 diff
(98.5 %id)
BX453595 fetal liver, Liver .o 467 to 831 365 to 1       365/512
(71 %)
8 diff
(98.5 %id)
BU633040 cell lines, Chondrosarcoma .o 467 to 1169 720 to 19   AAA   702/710
(98 %)
1 diff
(99.9 %id)
TI_154038084   .o 469 to 1169 775 to 79   AAA   697/799
(87 %)
18 diff
(97.8 %id)
BX335150 Placenta Cot 25-normalized .o 471 to 629 1 to 159   fully sequenced,   159/159
(100 %)
0 diff
(100 %id)
BF195663 fibrotheoma, ovary .o 471 to 1172 702 to 1       702/705
(99 %)
8 diff
(98.9 %id)
CV805926 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .o 473 to 1061 182 to 771       590/775
(76 %)
9 diff
(98.9 %id)
TI_154132909   .o 474 to 1169 800 to 105   AAA   696/696
(100 %)
4 diff
(99.5 %id)
BU627524 Bone, Enchondroma cell line .o 489 to 1172 702 to 19   AAA   684/684
(100 %)
0 diff
(100 %id)
BU625910 cell lines, Enchondroma .o 489 to 1172 701 to 19   AAA   683/683
(100 %)
4 diff
(99.5 %id)
CA308338 Alveolar Macrophage, lung .o 498 to 1169 685 to 15   AAA   671/671
(100 %)
1 diff
(99.9 %id)
BQ575683 Chondrosarcoma Grade II, Left Pelvis .o 501 to 1172 690 to 19   AAA   672/672
(100 %)
1 diff
(99.9 %id)
BE254564 eye, retinoblastoma .o 503 to 1151 1 to 643       643/745
(86 %)
21 diff
(97.2 %id)
BF440019 brain, glioblastoma (pooled) .o 504 to 1166 663 to 1       663/663
(100 %)
3 diff
(99.6 %id)
BU634089 cell lines, Chondrosarcoma .o 506 to 1172 685 to 19   AAA   667/667
(100 %)
0 diff
(100 %id)
AL527780 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .o 540 to 1139 599 to 1   fully sequenced,   599/599
(100 %)
4 diff
(99.4 %id)
AL579676 T cells (Jurkat cell line), T cells from T cell leukemia .o 540 to 1146 607 to 1   fully sequenced,   607/607
(100 %)
16 diff
(97.4 %id)
BX379224 Placenta Cot 25-normalized .o 540 to 1076 542 to 6   fully sequenced,   537/542
(99 %)
4 diff
(99.3 %id)
BX379295 Placenta Cot 25-normalized .o 540 to 1140 606 to 1   fully sequenced,   606/606
(100 %)
18 diff
(97.1 %id)
BX381353 Placenta Cot 25-normalized .o 540 to 1143 604 to 1   fully sequenced,   604/604
(100 %)
3 diff
(99.6 %id)
BX361008 Placenta Cot 25-normalized .o 540 to 1142 605 to 1   fully sequenced,   605/605
(100 %)
7 diff
(98.9 %id)
BM510901 insulinoma, Pancreas .o 540 to 1172 648 to 16   fully sequenced, AAA   633/633
(100 %)
0 diff
(100 %id)
BU782977 insulinoma, Pancreas .o 540 to 1172 648 to 16   fully sequenced, AAA   633/633
(100 %)
0 diff
(100 %id)
BU786051 insulinoma, Pancreas .o 540 to 1172 648 to 16   fully sequenced, AAA   633/633
(100 %)
0 diff
(100 %id)
BU947678 insulinoma, Pancreas .o 544 to 1172 644 to 16   fully sequenced, AAA   629/629
(100 %)
0 diff
(100 %id)
BQ130179 insulinoma, Pancreas .o 553 to 1172 635 to 16   fully sequenced, AAA   620/620
(100 %)
0 diff
(100 %id)
AL561071 B cells from Burkitt lymphoma .o 561 to 1144 588 to 1   fully sequenced,   584/584
(100 %)
14 diff
(97.7 %id)
CA950227 Pancreas, Purified pancreatic islet .o 585 to 1173 589 to 1       589/589
(100 %)
5 diff
(99.2 %id)
BX335149 Placenta Cot 25-normalized .o 599 to 1141 543 to 1   fully sequenced,   543/543
(100 %)
5 diff
(99.1 %id)
BM876361 insulinoma, Pancreas .o 628 to 1172 560 to 16   fully sequenced, AAA   545/545
(100 %)
0 diff
(100 %id)
BQ272210 insulinoma, Pancreas .o 628 to 1172 560 to 16   fully sequenced, AAA   545/545
(100 %)
0 diff
(100 %id)
BQ271039 Pancreas, Purified pancreatic islet .o 628 to 1171 545 to 2   fully sequenced,   544/545
(99 %)
0 diff
(100 %id)
BQ286633 Pancreas, Purified pancreatic islet .o 628 to 1172 545 to 1   fully sequenced,   545/545
(100 %)
1 diff
(99.9 %id)
BQ776634 Pancreas, Purified pancreatic islet .o 628 to 1173 550 to 6   fully sequenced,   545/550
(99 %)
0 diff
(100 %id)
BM661517 eye, Retina Foveal and Macular .o 628 to 1172 560 to 16   fully sequenced, AAA   545/545
(100 %)
0 diff
(100 %id)
AW162019 brain, frontal lobe .o 648 to 1173 532 to 7   fully sequenced,   526/532
(98 %)
0 diff
(100 %id)
DB365595   .o 657 to 1165 512 to 1   fully sequenced,   512/512
(100 %)
8 diff
(98.5 %id)
AW575396 lymph .o 674 to 1169 509 to 14   fully sequenced, AAA   496/496
(100 %)
0 diff
(100 %id)
BM666113 eye, fetal eyes .o 697 to 1172 491 to 16   fully sequenced, AAA   476/476
(100 %)
0 diff
(100 %id)
CB068301 Pancreas, Purified pancreatic islet .o 701 to 1171 471 to 1   fully sequenced,   471/471
(100 %)
2 diff
(99.6 %id)
BU727145 eye, eye anterior segment .o 715 to 1172 476 to 19   AAA   458/458
(100 %)
2 diff
(99.6 %id)
W80466 heart .o 734 to 1173 441 to 1   fully sequenced,   441/441
(100 %)
3 diff
(99.4 %id)
BU787624 insulinoma, Pancreas .o 743 to 1172 445 to 16   fully sequenced, AAA   430/430
(100 %)
0 diff
(100 %id)
BM126797 Islets of Langerhans, Pancreas .o 765 to 1172 420 to 13   fully sequenced, AAA   408/408
(100 %)
1 diff
(99.8 %id)
CB217444 mandible, pooled .o 779 to 1172 458 to 64   fully sequenced, AAA   395/395
(100 %)
22 diff
(94.5 %id)
T69791 liver and spleen .o 785 to 1162 388 to 1       388/388
(100 %)
12 diff
(97.0 %id)
W60079 Pancreas, pancreatic islet .o 786 to 1173 390 to 1   fully sequenced,   390/390
(100 %)
2 diff
(99.5 %id)
N21267 melanocyte .o 787 to 1172 388 to 1   fully sequenced,   388/388
(100 %)
3 diff
(99.3 %id)
N79791 lung .o 787 to 1172 397 to 12   AAA   386/386
(100 %)
1 diff
(99.8 %id)
N89904 lung .o 787 to 1172 386 to 1       386/386
(100 %)
2 diff
(99.5 %id)
AA132426   .o 787 to 1172 413 to 27   AAA   387/387
(100 %)
3 diff
(99.3 %id)
R97377 liver and spleen .o 815 to 1137 333 to 1       333/366
(90 %)
13 diff
(96.5 %id)
H73965 liver and spleen .o 823 to 1169 361 to 5       357/407
(87 %)
0 diff
(100 %id)
AA455649 germinal center B cell .o 851 to 1173 323 to 1   fully sequenced,   323/323
(100 %)
0 diff
(100 %id)
H69725 liver and spleen .o 894 to 1153 286 to 23       264/286
(92 %)
0 diff
(100 %id)
W31380 parathyroid gland, parathyroid tumor .o 1002 to 1169 184 to 17   AAA   168/168
(100 %)
1 diff
(99.5 %id)
BU948060 insulinoma, Pancreas .o 1041 to 1172 148 to 17   AAA   132/132
(100 %)
0 diff
(100 %id)
CN311518 embryonic stem cells, cell lines H1, H7, andH9 .p 1 to 649 1 to 648 T9Q G10E I11F L12* tiling clone,   648/648
(100 %)
6 diff
(99.1 %id)
BM707424 eye, eye anterior segment .q 1 to 499 9 to 507 exact tiling clone, fully sequenced,   499/507
(98 %)
6 diff
(98.9 %id)
BU728388 eye, eye anterior segment .q 494 to 787 309 to 16   tiling clone, fully sequenced, AAA   294/294
(100 %)
1 diff
(99.7 %id)
BI481125 Native Retinal Pigment Epithelium sheets, retina .r 1 to 391 12 to 406   tiling clone,   395/406
(97 %)
8 diff
(98.1 %id)
TI_154061608   .r 210 to 952 832 to 91   tiling clone,   694/1043
(66 %)
35 diff
(96.7 %id)
BG288654 bladder, transitional cell papilloma, cell line .s 1 to 480 1 to 473 L40W G41V A42L Y43T Q44S ... tiling clone, AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 473/473
(100 %)
9 diff
(98.1 %id)
DA182042 amygdala .t 1 to 558 2 to 559 exact tiling clone, capped   558/558
(100 %)
0 diff
(100 %id)
AA045678 uterus .u 1 to 227 1 to 227   tiling clone,   227/231
(98 %)
2 diff
(99.2 %id)
BI762652 pooled colon, kidney, stomach .u 10 to 895 1 to 880 exact tiling clone, AAA   880/880
(100 %)
15 diff
(98.3 %id)
TI_57150711   .u 10 to 895 31 to 910 exact AAA   880/910
(96 %)
21 diff
(97.7 %id)
AA045679 uterus .u 474 to 898 426 to 1       426/426
(100 %)
2 diff
(99.6 %id)
EC577299 Prostate .u 535 to 647 1 to 108       108/108
(100 %)
9 diff
(91.7 %id)
BG574399 breast, mammary adenocarcinoma, cell line .u 550 to 891 1 to 342   AAA   342/342
(100 %)
1 diff
(99.8 %id)
AA570008 breast .u 558 to 895 338 to 1       338/338
(100 %)
0 diff
(100 %id)
AA505366 breast .u 559 to 898 340 to 1       340/340
(100 %)
1 diff
(99.8 %id)
AA836918 Kidney, kidney tumor .u 559 to 899 341 to 1       341/341
(100 %)
1 diff
(99.8 %id)
AA846240 parathyroid gland, parathyroid tumor .u 561 to 898 355 to 18   AAA   338/338
(100 %)
0 diff
(100 %id)
AA574162 breast .u 562 to 897 336 to 1       336/336
(100 %)
0 diff
(100 %id)
AI189939 placenta .u 562 to 899 339 to 2       338/339
(99 %)
0 diff
(100 %id)
AI538660 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .u 569 to 895 327 to 1       327/327
(100 %)
1 diff
(99.7 %id)
AI873685 serous papillary carcinoma, high grade, 2pooled tumors, uterus .u 571 to 899 329 to 1   tiling clone,   329/329
(100 %)
0 diff
(100 %id)
BE765686 nervous_tumor .u 572 to 760 189 to 1       189/189
(100 %)
2 diff
(99.0 %id)
AI573053 lymph node, lymphoma, follicular mixed small and largecell .u 572 to 899 328 to 1       328/328
(100 %)
0 diff
(100 %id)
AW517926 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .u 572 to 899 326 to 1       326/326
(100 %)
4 diff
(98.8 %id)
AI362342 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .u 573 to 898 326 to 1       326/326
(100 %)
1 diff
(99.7 %id)
AW198013 adenocarcinoma, Pancreas .u 573 to 899 330 to 1       330/330
(100 %)
6 diff
(98.2 %id)
AA654253 epithelium (cell line), Prostate .u 574 to 895 322 to 1       322/322
(100 %)
0 diff
(100 %id)
GD142498   .u 593 to 895 1 to 303   AAA   303/303
(100 %)
7 diff
(97.7 %id)
EH338042   .u 601 to 669 1 to 69       69/69
(100 %)
0 diff
(100 %id)
FN117795 breast carcinoma .u 607 to 682 1 to 77       77/77
(100 %)
1 diff
(98.8 %id)
AI301991 carcinoid, lung .u 610 to 899 293 to 3       291/293
(99 %)
0 diff
(100 %id)
AI349594 lung .u 610 to 899 293 to 4       290/293
(98 %)
0 diff
(100 %id)
AV737904 cord Blood .u 613 to 891 1 to 270   AAA   270/270
(100 %)
12 diff
(95.6 %id)
F13802   .u 616 to 895 292 to 13   AAA   280/280
(100 %)
1 diff
(99.7 %id)
AW439161 large cell carcinoma, lung .u 617 to 898 299 to 18   AAA   282/289
(97 %)
0 diff
(100 %id)
AW439162 large cell carcinoma, lung .u 617 to 898 299 to 18   AAA   282/289
(97 %)
0 diff
(100 %id)
AW439165 large cell carcinoma, lung .u 617 to 898 299 to 18   AAA   282/289
(97 %)
1 diff
(99.7 %id)
AI784471 anaplastic oligodendroglioma, brain .u 618 to 899 283 to 1       283/283
(100 %)
2 diff
(99.3 %id)
AW439156 large cell carcinoma, lung .u 632 to 898 284 to 18   AAA   267/267
(100 %)
0 diff
(100 %id)
AA708668 pineal gland .u 635 to 899 269 to 5       265/269
(98 %)
0 diff
(100 %id)
AA367111 Pancreas .u 637 to 898 1 to 262       262/262
(100 %)
0 diff
(100 %id)
AV741537 cord Blood .u 639 to 891 22 to 263   AAA   242/263
(92 %)
6 diff
(97.8 %id)
N56343   .u 642 to 808 1 to 163       163/169
(96 %)
11 diff
(93.5 %id)
FN103497 breast carcinoma .u 647 to 753 106 to 1     Submitted on the opposite strand 106/106
(100 %)
3 diff
(97.2 %id)
AI206671 lung .u 651 to 896 246 to 1       246/246
(100 %)
1 diff
(99.6 %id)
AW002325 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .u 654 to 897 245 to 2       244/245
(99 %)
0 diff
(100 %id)
BG206169   .u 662 to 899 270 to 33     Submitted on the opposite strand 238/270
(88 %)
0 diff
(100 %id)
AA779494   .u 669 to 895 227 to 1       227/227
(100 %)
6 diff
(97.4 %id)
BF906771 stomach .u 675 to 825 153 to 1     Submitted on the opposite strand 153/153
(100 %)
7 diff
(95.5 %id)
FN171266 breast carcinoma .u 683 to 799 1 to 114       114/114
(100 %)
6 diff
(94.8 %id)
AA303398 aorta .u 691 to 898 1 to 208       208/208
(100 %)
1 diff
(99.6 %id)
T89607 liver and spleen .u 691 to 897 207 to 1       207/207
(100 %)
1 diff
(99.6 %id)
AW952011   .u 692 to 898 1 to 207   AAA   207/207
(100 %)
1 diff
(99.6 %id)
AI811438 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .u 695 to 898 204 to 1       204/204
(100 %)
1 diff
(99.6 %id)
Z40504 brain, total brain .u 700 to 895 199 to 4       196/199
(98 %)
0 diff
(100 %id)
AI244847 Kidney .u 701 to 898 198 to 1       198/198
(100 %)
1 diff
(99.5 %id)
BU589202 mixed (pool of 40 RNAs) .u 710 to 896 1 to 187       187/224
(83 %)
3 diff
(98.7 %id)
AA365262 pineal body .u 716 to 897 1 to 182       182/242
(75 %)
1 diff
(99.6 %id)
AI887408 serous papillary carcinoma, high grade, 2pooled tumors, uterus .u 747 to 898 152 to 1       152/152
(100 %)
0 diff
(100 %id)
AA827043 epithelium (cell line), Prostate .u 749 to 898 150 to 1       150/150
(100 %)
0 diff
(100 %id)
FN077510 breast carcinoma .u 759 to 841 14 to 96       83/97
(85 %)
4 diff
(95.9 %id)
BE728826 melanotic melanoma, skin .va 1 to 835 1 to 833 exact tiling clone,   833/934
(89 %)
30 diff
(96.8 %id)
BQ270739 insulinoma, Pancreas .va 18 to 117 8 to 107       100/107
(93 %)
6 diff
(94.4 %id)
BQ270499 insulinoma, Pancreas .va 278 to 898 637 to 17   tiling clone, AAA   621/621
(100 %)
0 diff
(100 %id)
AI202809 anaplastic oligodendroglioma, brain .vb 1 to 483 483 to 1 K15R L18W tiling clone,   483/483
(100 %)
3 diff
(99.4 %id)
BQ318516 colon .vb 9 to 125 8 to 124   tiling clone,   117/124
(94 %)
6 diff
(95.2 %id)
FN153064 breast carcinoma .vb 50 to 121 1 to 72       72/73
(98 %)
1 diff
(98.7 %id)
BF739965 Kidney .vb 140 to 483 344 to 1   tiling clone,   344/344
(100 %)
1 diff
(99.8 %id)
AA223846   .vc 1 to 296 1 to 299 C41X W55X H58X C60X Y78V ... tiling clone,   299/302
(99 %)
9 diff
(97.1 %id)
BM477776 leiomyosarcoma, uterus .vc 2 to 718 1 to 716 Q4S R5V A6P V7S P8L ... AAA   716/734
(97 %)
4 diff
(99.5 %id)
BG255156 adenocarcinoma, cell line, Prostate .vc 215 to 710 1 to 495   AAA   495/495
(100 %)
3 diff
(99.4 %id)
AW079935 esophagus, squamous cell carcinoma .vc 216 to 714 500 to 1       500/500
(100 %)
5 diff
(99.0 %id)
AI983698 brain, three pooled meningiomas .vc 217 to 714 499 to 1       499/499
(100 %)
1 diff
(99.8 %id)
AI423011 brain, glioblastoma (pooled) .vc 218 to 717 500 to 1       500/500
(100 %)
0 diff
(100 %id)
H96478 pineal gland .vc 225 to 601 1 to 379       379/379
(100 %)
4 diff
(99.0 %id)
AI149371 placenta .vc 226 to 718 494 to 2   tiling clone,   493/494
(99 %)
0 diff
(100 %id)
AW055058 brain, glioblastoma (pooled) .vc 227 to 717 501 to 11   AAA   491/491
(100 %)
0 diff
(100 %id)
BE463645 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .vc 227 to 717 491 to 1       491/491
(100 %)
0 diff
(100 %id)
DB568858 hypothalamus .vc 230 to 717 1 to 491     Submitted on the opposite strand 491/491
(100 %)
2 diff
(99.6 %id)
BU536803 mixed (pool of 40 RNAs) .vc 232 to 714 1 to 483   AAA   483/483
(100 %)
3 diff
(99.4 %id)
AW055150 brain, glioblastoma (pooled) .vc 251 to 710 461 to 1       461/461
(100 %)
4 diff
(99.2 %id)
AA974414 pooled germ cell tumors .vc 252 to 713 462 to 1       462/462
(100 %)
0 diff
(100 %id)
DB576357 hypothalamus .vc 253 to 717 1 to 465     Submitted on the opposite strand 465/465
(100 %)
0 diff
(100 %id)
BE620168 large cell carcinoma, undifferentiated, lung .vc 255 to 710 1 to 453       453/453
(100 %)
9 diff
(98.1 %id)
AW152458 serous papillary carcinoma, high grade, 2pooled tumors, uterus .vc 277 to 718 451 to 8       444/451
(98 %)
0 diff
(100 %id)
AI354756 lung .vc 281 to 718 440 to 3       438/440
(99 %)
0 diff
(100 %id)
CB053580 leiomyosarcoma, soft tissue .vc 283 to 713 14 to 445       432/445
(97 %)
6 diff
(98.7 %id)
BE765713 nervous_tumor .vc 284 to 579 295 to 1       295/330
(89 %)
2 diff
(99.4 %id)
AA740167 2 pooled tumors (clear cell type), Kidney .vc 287 to 716 436 to 6       431/436
(98 %)
0 diff
(100 %id)
AA887421 Kidney .vc 291 to 718 430 to 3       428/430
(99 %)
0 diff
(100 %id)
TI_154011509   .vc 292 to 720 545 to 111   tiling clone, AAA   435/924
(47 %)
12 diff
(98.8 %id)
AA657765   .vc 296 to 493 1 to 200       200/200
(100 %)
2 diff
(99.0 %id)
AW261898 brain, three pooled meningiomas .vc 300 to 717 418 to 1       418/418
(100 %)
0 diff
(100 %id)
AA831991 germinal center B cell .vc 301 to 717 443 to 27   AAA   417/417
(100 %)
0 diff
(100 %id)
BX281164 brain, hypothalamus .vc 305 to 717 445 to 29   AAA Submitted on the opposite strand 417/424
(98 %)
3 diff
(99.3 %id)
AW044054 brain, glioblastoma (pooled) .vc 307 to 710 407 to 1       407/408
(99 %)
4 diff
(99.1 %id)
DB559377 hypothalamus .vc 310 to 717 1 to 406   AAA Submitted on the opposite strand 406/406
(100 %)
4 diff
(99.1 %id)
AA224326.
matches multiple genes
  .vc 310 to 718 421 to 5     also hits gene COMMD4 417/425
(98 %)
0 diff
(100 %id)
CN260938 embryonic stem cells, DMSO-treated H9 cellline .vc 311 to 706 1 to 396       396/396
(100 %)
1 diff
(99.8 %id)
AA837569 epithelium (cell line), Prostate .vc 318 to 714 399 to 1       399/399
(100 %)
4 diff
(99.0 %id)
BG928250 cartilage .vc 330 to 654 84 to 408       325/342
(95 %)
6 diff
(98.3 %id)
N89901 lung .vc 330 to 717 393 to 1       393/393
(100 %)
7 diff
(98.3 %id)
BF941505 brain, glioblastoma (pooled) .vc 344 to 717 374 to 1       374/374
(100 %)
4 diff
(99.0 %id)
AA719147   .vc 349 to 716 370 to 3       368/370
(99 %)
0 diff
(100 %id)
BQ676612 melanotic melanoma, cell line, skin .vc 356 to 657 1 to 302       302/302
(100 %)
1 diff
(99.7 %id)
AI423686 brain, glioblastoma (pooled) .vc 368 to 600 232 to 1       232/236
(98 %)
1 diff
(99.6 %id)
AA743522 germinal center B cell .vc 379 to 717 366 to 28   AAA   339/339
(100 %)
0 diff
(100 %id)
AA654503 lymph node, lymphoma .vc 381 to 716 337 to 2       336/337
(99 %)
0 diff
(100 %id)
AA781298.
matches multiple genes
parathyroid gland, parathyroid tumor .vc 393 to 718 331 to 6   tiling clone, also hits gene korsmey 326/331
(98 %)
0 diff
(100 %id)
EC472890 Prostate .vc 402 to 493 1 to 90       90/90
(100 %)
4 diff
(95.6 %id)
CB136963 Liver .vc 423 to 700 1 to 278       278/278
(100 %)
0 diff
(100 %id)
BQ305199 breast .vc 432 to 583 156 to 3       154/171
(90 %)
0 diff
(100 %id)
CA774563 Pancreas, Purified pancreatic islet .vc 442 to 718 280 to 4       277/280
(98 %)
0 diff
(100 %id)
BQ440964 melanotic melanoma, skin .vc 448 to 714 21 to 287   AAA   267/287
(93 %)
6 diff
(98.0 %id)
BY999792   .vc 478 to 716 1 to 239     Submitted on the opposite strand 239/240
(99 %)
1 diff
(99.6 %id)
AI419601 brain, glioblastoma (pooled) .vc 485 to 710 226 to 1       226/226
(100 %)
0 diff
(100 %id)
R07113 liver and spleen .vc 510 to 711 202 to 1       202/202
(100 %)
0 diff
(100 %id)
AI624319 Kidney, renal cell tumor .vc 513 to 717 205 to 1       205/205
(100 %)
0 diff
(100 %id)
AI799515.
matches multiple genes
ovary, tumor, 5 pooled (see description) .vc 603 to 710 108 to 1     also hits gene korsmey 108/108
(100 %)
0 diff
(100 %id)
BM459733 leiomyosarcoma, uterus .vd 1 to 704 1 to 704 exact tiling clone, AAA   704/704
(100 %)
11 diff
(98.5 %id)
BU601872 mixed (pool of 40 RNAs) .vd 17 to 708 1 to 692   tiling clone,   692/696
(99 %)
7 diff
(99.0 %id)
NM_001127711.1   .ve 1 to 862 1 to 862 exact RefSeq, AAA   862/862
(100 %)
0 diff
(100 %id)
BU600020 mixed (pool of 40 RNAs) .ve 42 to 323 1 to 282   tiling clone, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 282/316
(89 %)
2 diff
(99.4 %id)
BP249229 Kidney .ve 44 to 552 1 to 509 exact     509/515
(98 %)
1 diff
(99.9 %id)
BP313071 mammary gland .ve 44 to 630 1 to 588 exact     588/588
(100 %)
2 diff
(99.7 %id)
BE894109 melanotic melanoma, skin .ve 50 to 644 1 to 595 exact     595/953
(62 %)
8 diff
(99.2 %id)
BF182781 large cell carcinoma, lung .ve 55 to 804 1 to 762 W13G F14L G15A F16L G17A ... tiling clone,   762/821
(92 %)
44 diff
(94.7 %id)
BG612688 embryonal carcinoma, testis .ve 59 to 688 1 to 630 exact     630/846
(74 %)
15 diff
(98.3 %id)
BG779200 adenocarcinoma, Prostate .ve 66 to 774 1 to 715 exact tiling clone,   715/721
(99 %)
19 diff
(97.4 %id)
BF243942 bone marrow, from acute myelogenous leukemia .ve 71 to 758 1 to 694 L11C H12A W13L F14V G15V ...     694/762
(91 %)
45 diff
(94.1 %id)
BG122184 adenocarcinoma, cell line, Liver .ve 79 to 323 1 to 240   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 243/247
(98 %)
19 diff
(92.4 %id)
BG470444 eye, retinoblastoma .ve 88 to 866 1 to 781 exact tiling clone, AAA   781/781
(100 %)
28 diff
(96.5 %id)
BM887873 eye .ve 210 to 722 1 to 513   tiling clone,   513/513
(100 %)
0 diff
(100 %id)
DA563445 heart .vf 1 to 566 2 to 567 exact tiling clone, capped   566/566
(100 %)
0 diff
(100 %id)
DA491993 brain .vf 167 to 728 2 to 563 exact tiling clone, capped   562/562
(100 %)
2 diff
(99.7 %id)
BU954174 mixed (pool of 40 RNAs) .vg 1 to 527 4 to 530 exact tiling clone,   530/535
(99 %)
7 diff
(98.7 %id)
AI245848 Kidney .vg 82 to 517 436 to 1 F6S     436/436
(100 %)
2 diff
(99.6 %id)
BF749645 breast_normal .vg 88 to 321 1 to 234       234/234
(100 %)
3 diff
(98.8 %id)
TI_149280189   .vg 324 to 517 272 to 79   AAA   194/1063
(18 %)
1 diff
(100.0 %id)
BM969857 lung, Primary Lung Epithelial Cells .vg 324 to 517 212 to 19   AAA   194/250
(77 %)
1 diff
(99.6 %id)
BU954633 mixed (pool of 40 RNAs) .vh 1 to 717 1 to 728 exact tiling clone,   728/836
(87 %)
14 diff
(98.4 %id)
BF176359 blood .vi 1 to 221 1 to 222   tiling clone,   222/224
(99 %)
6 diff
(97.4 %id)
H03161 placenta .vi 164 to 507 1 to 348   tiling clone,   348/348
(100 %)
5 diff
(98.6 %id)
H03968 placenta .vi 578 to 914 340 to 1   tiling clone,   340/340
(100 %)
7 diff
(98.0 %id)
BX090270 lung .vi 720 to 1192 1 to 473   tiling clone,   473/473
(100 %)
3 diff
(99.4 %id)
BX487605   .vi 825 to 1358 7 to 540   tiling clone,   534/540
(98 %)
6 diff
(98.9 %id)
AI888466 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .vi 1157 to 1641 485 to 1   tiling clone,   485/485
(100 %)
6 diff
(98.8 %id)
AL711757 human skeletal muscle .vi 1278 to 1830 554 to 1   tiling clone, Submitted on the opposite strand 554/554
(100 %)
6 diff
(99.0 %id)
AW205900   .vj 1 to 338 358 to 15 exact tiling clone, AAA   341/353
(96 %)
1 diff
(99.8 %id)
TI_153989922   .vj 1 to 338 435 to 92 exact AAA   341/638
(53 %)
1 diff
(99.9 %id)
BU580893 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .vk 1 to 565 1 to 566 exact tiling clone,   566/566
(100 %)
1 diff
(99.9 %id)
BU580431 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .vk 71 to 656 587 to 1   tiling clone,   587/587
(100 %)
1 diff
(99.9 %id)
AK311340 brain .vl 1 to 1586 4 to 1589 exact tiling clone,   1589/1589
(100 %)
0 diff
(100 %id)
DA519244 brain .vl 1 to 529 4 to 532 exact capped   531/532
(99 %)
1 diff
(99.9 %id)
BF690990 melanotic melanoma, high MDR, skin .vl 99 to 335 1 to 233 W13G F14W G15L F16W G17L ... AAA   233/392
(59 %)
6 diff
(98.5 %id)
AI524703 B-cell, chronic lymphotic leukemia .vl 300 to 390 91 to 1       91/91
(100 %)
4 diff
(95.7 %id)
AI284111 esophagus, squamous cell carcinoma .vm-u 1 to 422 422 to 1 exact tiling clone,   422/422
(100 %)
0 diff
(100 %id)
AI284112 esophagus, squamous cell carcinoma .vm-u 96 to 422 327 to 1       327/327
(100 %)
1 diff
(99.7 %id)
CR592352 Placenta Cot 25-normalized .vm-u 296 to 1405 1 to 1110   tiling clone,   1110/1110
(100 %)
0 diff
(100 %id)
AL571381 placenta, Placenta Cot 25-normalized .vm-u 296 to 1405 1 to 1109   fully sequenced,   1109/1109
(100 %)
3 diff
(99.8 %id)
H78867 liver and spleen .vm-u 383 to 787 1 to 415       415/429
(96 %)
14 diff
(96.8 %id)
DA573089 whole embryo, mainly body .vm-u 521 to 1354 2 to 833   capped   832/832
(100 %)
5 diff
(99.4 %id)
AL545732 placenta, Placenta Cot 25-normalized .vm-u 835 to 1385 551 to 1   fully sequenced,   551/551
(100 %)
5 diff
(99.1 %id)
H80110 liver and spleen .vm-u 1019 to 1421 424 to 7   tiling clone,   418/424
(98 %)
0 diff
(100 %id)
BU663953 blood .vn-u 1 to 552 2 to 552 F47X L49C F50L V51F L53C ... tiling clone,   551/552
(99 %)
7 diff
(98.8 %id)
EL955175 eyeball .vn-u 428 to 964 1 to 537   tiling clone,   537/537
(100 %)
12 diff
(97.8 %id)
BG913057 anaplastic oligodendroglioma with 1p/19qloss, brain .vo-u 1 to 655 1 to 654 exact tiling clone,   654/654
(100 %)
7 diff
(99.0 %id)
BF832782 head_neck .vo-u 636 to 836 36 to 234   tiling clone,   199/243
(81 %)
8 diff
(96.8 %id)
DW462101 Liver .vo-u 845 to 948 17 to 120   tiling clone,   104/120
(86 %)
6 diff
(95.0 %id)
T84744 liver and spleen .vp-u 1 to 334 6 to 350   tiling clone,   345/388
(88 %)
17 diff
(95.7 %id)
R11287 liver and spleen .vp-u 8 to 332 1 to 335   tiling clone,   335/335
(100 %)
11 diff
(96.8 %id)
T92035 liver and spleen .vp-u 378 to 838 462 to 1 exact tiling clone,   462/462
(100 %)
3 diff
(99.4 %id)
R11228 liver and spleen .vp-u 526 to 838 318 to 1       318/364
(87 %)
10 diff
(97.3 %id)
BG483916 lung .vq 1 to 681 1 to 676 exact tiling clone,   676/676
(100 %)
9 diff
(98.7 %id)
F31686 pectoral muscle (after mastectomy) .vq 369 to 622 1 to 254   tiling clone,   254/254
(100 %)
3 diff
(98.9 %id)
DA481439   .vr-u 1 to 540 2 to 541   tiling clone, capped   540/541
(99 %)
1 diff
(99.9 %id)
DB012073 esophageal, tumor tissue .vr-u 37 to 601 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
DA214808 brain .vr-u 97 to 633 2 to 540   capped   539/539
(100 %)
5 diff
(99.1 %id)
DA289804 hippocampus .vr-u 97 to 677 2 to 583 exact tiling clone, capped   582/582
(100 %)
1 diff
(99.9 %id)
DB258708 uterus .vs 1 to 559 2 to 560 exact tiling clone, capped   559/559
(100 %)
1 diff
(99.9 %id)
CV356057 nervous_normal .vs 363 to 632 285 to 18   tiling clone, Submitted on the opposite strand 268/285
(94 %)
0 diff
(100 %id)
DA508140 brain .vt 1 to 564 2 to 566 exact tiling clone, capped   565/565
(100 %)
1 diff
(99.9 %id)
TI_57163246   .vu 1 to 560 33 to 592 P11H P12R G13D R14G R15E ... tiling clone,   488/593
(82 %)
16 diff
(97.4 %id)
BI838112 pooled pancreas and spleen .vu 4 to 560 1 to 557   tiling clone,   483/558
(86 %)
11 diff
(98.1 %id)
DA266984 caudate nucleus .vv 1 to 512 5 to 516 exact tiling clone, capped   515/515
(100 %)
2 diff
(99.7 %id)
DA090111 cerebellum .vv 4 to 554 2 to 552 exact tiling clone, capped   551/553
(99 %)
15 diff
(97.3 %id)
DA215974 brain .vw 1 to 501 2 to 502 exact tiling clone, capped   501/501
(100 %)
0 diff
(100 %id)
AA931848 Kidney .vx 1 to 482 481 to 1 exact tiling clone,   481/481
(100 %)
1 diff
(99.8 %id)
AA115860 lung, lung carcinoma .vy 1 to 152 1 to 154   tiling clone, fully sequenced,   154/154
(100 %)
1 diff
(99.4 %id)
AA115861 lung, lung carcinoma .vy 91 to 468 384 to 1 C30V S31L V32C R33T I34H ... tiling clone, fully sequenced,   384/384
(100 %)
5 diff
(98.7 %id)
AW294808   .vz 1 to 371 389 to 17 exact tiling clone, AAA   372/382
(97 %)
2 diff
(99.5 %id)
AW939020 denis_drash .wa-u 1 to 370 1 to 368 L5I L10G G11F L12E P14Q ... tiling clone,   368/371
(99 %)
5 diff
(98.7 %id)
AW939053 denis_drash .wa-u 12 to 302 295 to 1   tiling clone, Submitted on the opposite strand 295/295
(100 %)
11 diff
(96.3 %id)
C17789 placenta .wb-u 1 to 348 1 to 353 E36D H37T L38P E39* tiling clone,   353/355
(99 %)
12 diff
(96.7 %id)
D78862 placenta .wb-u 1 to 302 1 to 302 V49C E50G tiling clone,   302/302
(100 %)
4 diff
(98.7 %id)
D78902 placenta .wb-u 1 to 341 29 to 369 exact tiling clone,   341/369
(92 %)
7 diff
(98.2 %id)
AA442215.
matches multiple genes
  .wc 1 to 293 293 to 1 A25G tiling clone, Submitted on the opposite strand, also hits gene nora 293/293
(100 %)
1 diff
(99.7 %id)
H96200 pineal gland .wd 1 to 287 1 to 292 exact tiling clone,   292/294
(99 %)
11 diff
(96.3 %id)
GD144260   .we 1 to 195 200 to 6 K5* tiling clone, Submitted on the opposite strand 195/201
(97 %)
2 diff
(99.1 %id)
AI989504 pooled germ cell tumors .we 38 to 216 180 to 1       180/230
(78 %)
0 diff
(100 %id)
BG219741   .we 49 to 219 1 to 171   tiling clone,   171/181
(94 %)
3 diff
(98.4 %id)
AA307572 aorta Gene TMEM14CandTMEM14BandSYCP2L, variant not shown         This clone was ignored    
AK128130 testis Gene TMEM14CandTMEM14BandSYCP2L, variant not shown       available from FLJ, This clone was ignored    
AM293674   Gene TMEM14CandTMEM14BandSYCP2L, variant not shown       AAA This clone was ignored    
DB295843   Gene TMEM14CandTMEM14BandSYCP2L, variant not shown         This clone was ignored    
DA033831   Gene TMEM14CandTMEM14BandSYCP2L, variant not shown       capped This clone was ignored    
TI_1968233113   Gene TMEM14CandTMEM14BandSYCP2L, variant not shown         Submitted on the opposite strand    
CN275877 embryonic stem cells, DMSO-treated H9 cellline Gene TMEM14CandTMEM14BandSYCP2L, variant not shown              
DB313377 tongue, tumor tissue Gene TMEM14CandTMEM14BandSYCP2L, variant not shown              
DA435706 tongue, tumor tissue Gene TMEM14CandTMEM14BandSYCP2L, variant not shown       capped      
BX470455   Gene TMEM14CandTMEM14BandSYCP2L, variant not shown       fully sequenced, AAA Suspected internal deletion, this clone was ignored    
BX470456   Gene TMEM14CandTMEM14BandSYCP2L, variant not shown       fully sequenced, AAA Suspected internal deletion, this clone was ignored    
H73369 liver and spleen Gene TMEM14CandTMEM14BandSYCP2L, variant not shown       fully sequenced, This clone was ignored    
H74189 liver and spleen Gene TMEM14CandTMEM14BandSYCP2L, variant not shown       fully sequenced, This clone was ignored    
N78889.
matches multiple genes
lung Gene TMEM14CandTMEM14BandSYCP2L, variant not shown       fully sequenced, This clone was ignored, also hits gene morsmaby    
N78889.
matches multiple genes
lung Gene morsmaby, variant not shown       fully sequenced, This clone was ignored, also hits gene morsmaby    
W06975.
matches multiple genes
lung Gene TMEM14CandTMEM14BandSYCP2L, variant not shown       fully sequenced, This clone was ignored, also hits gene morsmaby    
W06975.
matches multiple genes
lung Gene morsmaby, variant not shown       fully sequenced, This clone was ignored, also hits gene morsmaby    
BG249170 hypernephroma, cell line, Kidney Gene TMEM14CandTMEM14BandSYCP2L, variant not shown         This clone was ignored    
BM916878 amelanotic melanoma, cell line, skin Gene TMEM14CandTMEM14BandSYCP2L, variant not shown         Suspected internal deletion, this clone was ignored    
BQ227243 melanotic melanoma, skin Gene TMEM14CandTMEM14BandSYCP2L, variant not shown         This clone was ignored    
AV759501 bone marrow Gene TMEM14CandTMEM14BandSYCP2L, variant not shown         Suspected internal deletion, this clone was ignored    
NM_001040274.2   Gene TMEM14CandTMEM14BandSYCP2L, variant not shown       RefSeq, AAA This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb, .vc, .vd, .ve, .vf, .vg, .vh, .vi, .vj, .vk, .vl, .vm-u, .vn-u, .vo-u, .vp-u, .vq, .vr-u, .vs, .vt, .vu, .vv, .vw, .vx, .vy, .vz, .wa-u, .wb-u, .wc, .wd, .we Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DC